0001213900-21-028876.txt : 20210525 0001213900-21-028876.hdr.sgml : 20210525 20210524180256 ACCESSION NUMBER: 0001213900-21-028876 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 49 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210525 DATE AS OF CHANGE: 20210524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Edoc Acquisition Corp. CENTRAL INDEX KEY: 0001824884 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39689 FILM NUMBER: 21956607 BUSINESS ADDRESS: STREET 1: 7612 MAIN STREET FISHERS STREET 2: SUITE 200 CITY: VICTOR STATE: NY ZIP: 14564 BUSINESS PHONE: 5856781198 MAIL ADDRESS: STREET 1: 7612 MAIN STREET FISHERS STREET 2: SUITE 200 CITY: VICTOR STATE: NY ZIP: 14564 10-Q 1 f10q0321_edocacquisition.htm QUARTERLY REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No. 001-39689

EDOC ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

Cayman Islands

N/A

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

7612 Main Street Fishers Suite 200 Victor, NY 14564

(Address of Principal Executive Offices, including zip code)

(585) 678-1198

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A Ordinary Shares, $.0001 par value per share	ADOC	The Nasdaq Stock Market LLC
Rights, exchangeable into one-tenth of one Class A Ordinary Share	ADOCR	The Nasdaq Stock Market LLC
Warrants, each exercisable for one-half of one Class A Ordinary Share, each whole Warrant exercisable for $11.50 per share	ADOCW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

	☐ Large accelerated filer	☐ Accelerated filer
	☒ Non-accelerated filer	☒ Smaller reporting company
		☒ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☒ No ☐

As of May 24, 2021, there were 9,554,000 Class A ordinary shares, par value $0.0001 per share, and 2,250,000 Class B ordinary shares, par value $0.0001 per share, of the registrant issued and outstanding.

EDOC ACQUISITION CORP.

FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2021

TABLE OF CONTENTS

		Page
PART 1 – FINANCIAL INFORMATION

Item 1.	Financial Statements	1

	Condensed Balance Sheet (unaudited)	1

	Condensed Statement of Operations (unaudited)	2

	Condensed Statement of Changes in Shareholder’s Equity (unaudited)	3

	Condensed Statement of Cash Flows (unaudited)	4

	Notes to Condensed Financial Statements (unaudited)	5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	21

Item 4.	Control and Procedures	21

PART II – OTHER INFORMATION

Item 1.	Legal Proceedings	22

Item 1A.	Risk Factors	22

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	22

Item 3.	Defaults Upon Senior Securities	22

Item 4.	Mine Safety Disclosures	22

Item 5.	Other Information	22

Item 6.	Exhibits	23

SIGNATURES		24

Item 1. Financial Statements

EDOC ACQUISTION CORP.
CONDENSED BALANCE SHEETS

	March 31, 2021		December 31, 2020
	(unaudited)
Assets:
Current assets:
Cash	$	727,773	$	1,000,730
Prepaid expenses		311,831		97,498
Total current assets		1,047,599		1,098,228
Cash and marketable securities held in Trust Account		91,550,549		91,538,680
Total Assets	$	92,590,153	$	92,636,908

Liabilities and Shareholders’ Equity:
Current liabilities:
Accounts payable and accrued expenses	$	133,680	$	53,680
Due to related party		—		17,000
Total current liabilities		133,680		70,680
Warrant liability		420,123		1,156,512
Total Liabilities	$	553,803	$	1,227,192

Commitments and Contingencies
Class A ordinary shares subject to possible redemption, 8,558,147 shares at $10.17		87,036,350		86,409,715

Shareholders’ Equity:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding		—		—
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 995,853 and 1,057,469 issued and outstanding at March 31, 2021 and December 31, 2020 (excluding 8,558,147 shares subject to possible redemption)		99		105
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 2,250,000 and 2,250,000 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively		225		225
Additional paid-in capital		4,938,340		5,564,969
Accumulated surplus (deficit)		61,336		(565,298	)
Total Shareholders’ Equity		5,000,000		5,000,001
Total Liabilities and Shareholders’ Equity	$	92,590,153	$	92,636,908

See accompanying notes to interim condensed financial statements.

EDOC ACQUISTION CORP.
CONDENSED STATEMENT OF OPERATIONS

FOR THE THREE MONTHS ENDED MARCH 31, 2021

(UNAUDITED)

Formation and operating costs	$	121,624
Loss from operations		(121,624	)
Other income (expenses):
Amortized interest on marketable securities held in Trust Account		11,869
Change in fair value of warrants		736,389
Total other income		748,258
Net Income	$	626,634

Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption		8,496,531
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption	$	0.00
Basic and diluted weighted average shares outstanding, ordinary shares		3,307,469
Basic and diluted net loss per share, ordinary shares	$	0.19

See accompanying notes to financial statements.

EDOC ACQUISTION CORP.
CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY
FOR THE THREE MONTHS ENDED MARCH 31, 2021

(UNAUDITED)

	Ordinary shares										Additional						Total
	Class A						Class B				Paid-In			Accumulated			Shareholders’
	Shares			Amount			Shares		Amount		Capital			Deficit			Equity
Balance—December 31, 2020		1,057,469		$	105			2,250,000	$	225	$	5,564,969		$	(565,298	)		5,000,001

Net income															626,634			626,634

Class A ordinary shares subject to possible redemption		(61,616	)		(6	)						(626,629	)					(626,635	)

Balance—March 31, 2021		995,853		$	99			2,250,000	$	225	$	4,938,340		$	61,336		$	5,000,000

See accompanying notes to interim condensed financial statements.

EDOC ACQUISTION CORP.
CONDENSED STATEMENT OF CASH FLOWS
FOR THE THREE MONTHS ENDED MARCH 31, 2021

(UNAUDITED)

Cash flows from operating activities:
Net Income	$	626,634
Adjustments to reconcile net loss to net cash used in operating activities:
Amortized interest on cash and Treasury securities held in Trust Account		(11,869	)
Change in Fair Value of Warrant Liability		(736,389	)
Changes in operating assets and liabilities:
Prepaid expenses		(214,333	)
Due to related party		(17,000	)
Accounts payable and accrued expenses		80,000
Net cash used in operating activities		(272,957	)
Net change in cash		(272,957	)
Cash, beginning of the period		1,000,730
Cash, end of period	$	727,773
Supplemental disclosure of cash flow information:
Non-cash investing and financing transactions:
Change in value of Class A ordinary shares subject to possible redemption	$	626,635

See accompanying notes to interim condensed financial statements.

EDOC ACQUISTION CORP.
NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS

Unaudited

Note 1—Description of Organization, Business Operations and Basis of Presentation

EDOC Acquisition Corp. (the “Company”) was incorporated in the Cayman Islands on August 20, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). While the Company may pursue an acquisition opportunity in any industry or geographic region, the Company intends to focus on businesses primarily operating in the health care and health care provider space in North America and Asia-Pacific. The Company has selected December 31 as its fiscal year end.

As of March 31, 2021, the Company had not yet commenced any operations. All activity through March 31, 2021, relates to the Company’s formation and the Initial Public Offering (“IPO”) described below. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO.

The Company’s sponsor is American Physicians LLC (the “Sponsor”).

Financing

The registration statement for the Company’s initial public offering was declared effective on November 9, 2020 (the “Effective Date”). On November 12, 2020, the Company consummated the initial public offering of 9,000,000 units (each, a “Unit” and collectively, the “Units”) at $10.00 per Unit (the “Initial Public Offering” or “IPO”), which is discussed in Note 3.

Simultaneously with the closing of the IPO, the Company consummated the sale of 479,000 private placement units (“Private Unit)” and collectively, the “Private Units”), at a price of $10.00 per unit. Of the 479,000 private placement units, 65,000 units, or the “representative units” were purchased by I-Banker (and/or its designees). In addition, the Company’s sponsor agreed, pursuant to a letter agreement to purchase up to 3,750,000 of the Company’s rights in the open market at a market price not to exceed $0.20 per right. I-Bankers also agreed to purchase up to 1,250,000 of the Company’s rights in the open market at a market price not to exceed $0.20 per right, which is discussed in Note 4.

Transaction costs of the IPO amounted to $3,246,381, consisting of $1,575,000 of cash underwriting fees, the fair value of the representative’s warrants of $424,270, the fair value of representative’s shares $ 653,250 and $593,861 of other cash offering costs.

Trust Account

Following the closing of the IPO on November 12, 2020, $91,530,000 ($10.17 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (“Trust Account”) and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, until the earlier of: (i) the completion of a Business Combination, (ii) the redemption of any public shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation, and (iii) the redemption of the Company’s public shares if the Company is unable to complete the initial Business Combination within 24 months from the closing of the IPO (the “Combination Period”), subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholder.

Business Combination

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes and excluding the amount of any deferred underwriting discount held in trust) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). Upon the closing of the Proposed Public Offering, an amount equal to at least $10.00 per Unit sold in the Proposed Public Offering, including the proceeds from the sale of the Private Placement Warrants to the Sponsor, was placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. government securities,” within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

The Company will provide holders of the Company’s outstanding shares of Class A ordinary shares, par value $0.0001 per share, sold in the IPO (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares (as defined below) upon the completion of the initial business combination either (i) in connection with a shareholder meeting called to approve the initial business combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial business combination or conduct a tender offer will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially approximately $10.17 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations).

The ordinary shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the Proposed Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.

The Company will have 12 months (or up to 18 months if the Company extends the period of time) from the closing of the Proposed Public Offering to consummate a Business Combination (the “Combination Period”). However, if the Company is unable to complete a Business Combination within the Combination Period, the Company will redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the trust account, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to the Company to pay its franchise and income taxes, divided by the number of then outstanding public shares, subject to applicable law and as further described in registration statement, and then seek to dissolve and liquidate.

The Sponsor, officers and directors and Representative (defined in Note 6) have agreed to (i) waive their redemption rights with respect to their founder shares, private shares, and public shares in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to their founder shares, private shares, and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation, and (iii) waive their rights to liquidating distributions from the trust account with respect to their founder shares and private shares if the Company fails to complete the initial business combination within the Combination Period.

The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.17 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.17 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of this offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Company’s Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations.

Risks and Uncertainties

Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might results from the outcome of this uncertainty.

Liquidity

As of March 31, 2021, the Company had cash outside the Trust Account of $727,773 available for working capital needs. All remaining cash held in the Trust Account are generally unavailable for the Company’s use, prior to an initial business combination, and is restricted for use either in a Business Combination or to redeem ordinary shares. As of March 31, 2021 and December 31, 2020, none of the amount in the Trust Account was available to be withdrawn as described above.

Through March 31, 2021, the Company’s liquidity needs were satisfied through receipt of $25,000 from the sale of the founder shares and the remaining net proceeds from the IPO and the sale of Private Placement Warrants.

The Company anticipates that the $727,773 outside of the Trust Account as of March 31, 2021, will be sufficient to allow the Company to operate for at least the next 12 months from the issuance of the financial statements, assuming that a Business Combination is not consummated during that time. Until consummation of its Business Combination, the Company will be using the funds not held in the Trust Account, and any additional Working Capital Loans (as defined in Note 6) from the initial stockholders, the Company’s officers and directors, or their respective affiliates (which is described in Note 6), for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the Business Combination.

The Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the Company’s estimates of the costs of undertaking in-depth due diligence and negotiating business combination is less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the business combination. Moreover, the Company will need to raise additional capital through loans from its Sponsor, officers, directors, or third parties. None of the Sponsor, officers or directors are under any obligation to advance funds to, or to invest in, the Company. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of its business plan, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.

Risks and Uncertainties

On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the “COVID-19 outbreak”). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve. The impact of the COVID-19 outbreak on the Company’s financial position will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of the COVID-19 outbreak on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s financial position may be materially adversely affected. Additionally, the Company’s ability to complete an initial business combination may be materially adversely affected due to significant governmental measures being implemented to contain the COVID-19 outbreak or treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit the Company’s ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate an initial business combination in a timely manner. The Company’s ability to consummate an initial business combination may also be dependent on the ability to raise additional equity and debt financing, which may be impacted by the COVID-19 outbreak and the resulting market downturn.

Note 2—Summary of Significant Accounting Policies

Basis of Presentation

The accompanying financial statements of the Company is presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are necessary to present fairly the financial position, and the results of its operations and its cash flows.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Form 10-K for the period from August 20, 2020 (inception) through December 31, 2020 as filed with the SEC on May 24, 2021, which contains the audited financial statements and notes thereto.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of March 31, 2021, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Use of Estimates

The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting period and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.

Investment Held in Trust Account

At March 31, 2021, the Trust Account had $91,542,554 held in marketable securities. During period January 1, 2021 to March 31, 2021, the Company did not withdraw any of interest income from the Trust Account to pay its tax obligations.

Fair Value Measurements

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet.

Derivative warrant liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

The Company accounts for its 479,000 Private Warrants and 450,000 Representative’s Warrants issued in connection with its Initial Public Offering as derivative warrant liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued by the Company in connection with the Public Offering and Private Placement has been estimated using Monte-Carlo simulations at each measurement date.

Offering Costs Associated with IPO

The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering and that were charged to shareholders’ equity upon the completion of the IPO. Accordingly, on December 31, 2020, offering costs totaling $3,246,381 have been charged to shareholders’ equity (consisting of $1,575,000 of underwriting fee, the fair value of the representative’s warrants of $424,270, the fair value of representative’s shares $653,250 and $593,861 of other cash offering costs).

Class A Ordinary shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2021, 8,558,147 shares of Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

Net Loss Per Ordinary Share

Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for each of the periods. The calculation of diluted loss per ordinary share does not consider the effect of the warrants and rights issued in connection with the (i) IPO since the exercise of the warrants and rights are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants and rights are exercisable for 6,137,400 shares of Class A ordinary shares in the aggregate.

	For the Three Months ended March 31, 2021
Ordinary shares subject to possible redemption
Numerator: Net income allocable to Class A ordinary shares subject to possible redemption
Amortized Interest income on Treasury securities held in trust	$	10,632
Less: interest available to be withdrawn for payment of taxes		-
Net income allocable to Class A ordinary shares subject to possible redemption	$	10,632
Denominator: Weighted Average Redeemable Class A ordinary shares
Redeemable Class A Ordinary shares, Basic and Diluted		8,496,531
Basic and Diluted net income per share, Redeemable Class A Ordinary shares	$	0.00

Non-Redeemable Ordinary shares
Numerator: Net Income minus Redeemable Net Earnings
Net Income	$	626,634
Redeemable Net Loss		(10,632	)
Non-Redeemable Net Income	$	616,002
Denominator: Weighted Average Non-Redeemable Ordinary shares
Basic and diluted weighted average shares outstanding, ordinary shares		3,307,469
Basic and diluted net loss per share, ordinary shares	$	0.19

Income Taxes

The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect the total amount of unrecognized tax benefits will materially change over the next twelve months.

Recent Accounting Standards

The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Note 4—Initial Public Offering

Pursuant to the IPO, the Company sold 9,000,000 Units at a purchase price of $10.00 per unit. Each unit consists of one share of Class A ordinary shares, one-half warrant to purchase one share of Class A ordinary shares (“Public Warrants”), and one right (“Rights”). Each Public Warrant will entitle the holder to purchase one share of Class A ordinary shares at a price of $11.50 per share, subject to adjustment. Each Public Warrant will become exercisable on the later of the completion of the initial Business Combination or 12 months from the closing of the IPO and will expire five years after the completion of the initial Business Combination, or earlier upon redemption or liquidation (see Note 7). Each right entitles the holder to receive one-tenth (1/10) of one share of Class A ordinary shares upon the consummation of an initial Business Combination (see Note 7).

Note 5—Private Placement

Simultaneously with the closing of the IPO, the Sponsor and I-Bankers purchased an aggregate of 414,000 Private Units and 65,000 Private Units, respectively, for an aggregate of 479,000 Private Units at a price of $10.00 per Private Unit, for an aggregate purchase price of $4,790,000, in a private placement. A portion of the proceeds from the private placement was added to the proceeds from the IPO held in the Trust Account.

Each Private Unit is identical to the Units sold in the IPO, except that warrants that are part of the Private Placement Units (“Private Warrants”) are not redeemable by the Company so long as they are held by the original holders or their permitted transferees. In addition, for as long as the warrants that are part of the Private Placement Units are held by I-Bankers or its designees or affiliates, they may not be exercised after five years from the effective date of the Registration Statement.

The Company’s Sponsor, officers, and directors have agreed to (i) waive their redemption rights with respect to their founder shares, private shares, and public shares in connection with the completion of the Company’s initial Business Combination, (ii) waive their redemption rights with respect to the founder shares, private shares, and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if the Company does not complete its initial Business Combination within the Combination Period or (B) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares if the Company fails to complete its initial Business Combination the Combination Period. In addition, the Company’s Sponsor, officers, and directors have agreed to vote any founder shares, private shares, and public shares held by them and any public shares purchased during or after the IPO (including in open market and privately negotiated transactions) in favor of the Company’s initial business combination.

Note 6—Related Party Transactions

Founder Shares

In September 2020, the Sponsor subscribed 2,875,000 shares of the Company’s Class B ordinary shares for $25,000, or approximately $0.01 per share, in connection with formation. On November 9, 2020, the Sponsor surrendered an aggregate of 287,500 founder shares, which were cancelled, resulting in an aggregate of 2,587,500 founder shares outstanding and held by the Sponsor (see Note 7). The founder shares include an aggregate of up to 337,500 shares subject to forfeiture if the over-allotment option is not exercised by the underwriters in full. On December 24, 2020, 337,500 shares were forfeited as the over-allotment option was not exercised by the underwriters.

Promissory Note—Related Party

In September 2020, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000 to be used for a portion of the expenses of the IPO. This loan is non-interest bearing, unsecured and due at the earlier of June 30, 2021 or the closing of the IPO. As of November 12, 2020, the Sponsor had loaned to the Company an aggregate of $177,591 under the promissory note to pay for formation costs and a portion of the expenses of the IPO. The note was repaid in full in connection with the closing of our initial public offering, and as of March 31, 2021 and December 31, 2020 respectively, no amounts were outstanding.

Working Capital Loans

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, Up to $1,500,000 of such Working Capital Loans may be convertible upon consummation of our business combination into additional private units at a price of $10.00 per unit. At March 31, 2021 and December 31, 2020 respectively, no Working Capital Loans were outstanding. To date, the Company had no borrowings under the Working Capital Loans.

Administrative Support Agreement

The Company agreed, for a period commencing on November 9, 2020 and ending upon completion of the Company’s Business Combination or its liquidation, to pay the Company’s Sponsor a monthly fee of $10,000 for office space, utilities and secretarial and administrative support. Since the initial public offering, the Company has not made any payments under the agreement, and has paid for services rendered and expenses advanced by the Sponsor on an as-needed basis. Effective March 31, 2021, the Company and Sponsor terminated the agreement and agreed to waive any accrued fees from inception through March 31, 2021. As of March 31, 2021 no fees were due to the Sponsor.

The Sponsor, executive officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made to the Sponsor, officers, directors or their affiliates.

Note 7—Commitments and Contingencies

Registration Rights

The holders of the founder shares, private placement warrants, and warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement to be signed prior to or on the effective date of the IPO. These holders will be entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities in other registration statements filed by the Company.

Underwriting Agreement

On November 12, 2020, the Company issued to the underwriter (and/or its designees) (the “Representative”) 75,000 shares of Class A ordinary shares for $0.01 per share (the “Representative Shares”). The fair value of the Representative Shares was estimated to $653,250 and were treated as underwriters’ compensation and charged directly to shareholders’ equity.

The underwriter (and/or its designees) agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of the initial Business Combination and (ii) to waive its rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete its initial Business Combination within the Combination Period.

In addition, the Company issued to the Representative a warrant (“Representative’s Warrant) to purchase up to 450,000 Class A ordinary shares. Such warrants will not be redeemable for as long as they are held by the Representative and they may not be exercised after five years from the Effective Date of the registration statement. Except as described above, the warrants are identical to those underlying the units offered by in the IPO. The Company estimated the fair value of the Representative’s Warrant is $424,270 using the Monte Carlo simulation model. The fair value of the Representative’s Warrant to granted to the underwriters is estimated as of the date of grant using the following assumptions: (1) expected volatility of 24.1%, (2) risk-free interest rate of 0.60% and (3) expected life of 6.05 years. The expected volatility was determined by the Company based on the historical volatilities of a set of comparative special purpose acquisition companies (“SPAC”), and the risk-fee interest rate was determined by reference to the U.S. Treasury yield curve in effect for time period equals to the expected life of the Representative’s Warrant.

As of March 31, 2020, the over-allotment granted to the underwriters had expired unexercised. On November 12, 2020, the underwriters were paid a cash underwriting discount of 1.75% of the gross proceeds of the Initial Public Offering, or $1,575,000.

Business Combination Marketing Agreement

The Company engaged the Representative as an advisor in connection with its Business Combination to (i) assist the Company in preparing presentations for each potential Business Combination; (ii) assist the Company in arranging meetings with its shareholders, including making calls directly to shareholders, to discuss each potential Business Combination and each potential target’s attributes and providing regular market feedback, including written status reports, from these meetings and participate in direct interaction with shareholders, in all cases to the extent legally permissible; (iii) introduce the Company to potential investors to purchase the Company’s securities in connection with each potential Business Combination; and assist the Company with the preparation of any press releases and filings related to each potential Business Combination or target. Pursuant to the business combination marketing agreement, the Representative is not obligated to assist the Company in identifying or evaluating possible acquisition candidates. Pursuant to the Company’s agreement with the Representative, an advisory fee of 2.75% of the gross proceeds of the IPO, or $2,475,000 will be payable to the Representative at the closing of the Company’s Business Combination.

Open Market Purchases

Note 8 -Warrants and Rights

Warrants —Each whole warrant entitles the holder to purchase one share of the Company’s Class A ordinary shares at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.50 per share of Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Company’s Sponsor or its affiliates, without taking into account any founder shares held by the Company’s Sponsor or its affiliates, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Value, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the Market Value.

The warrants will become exercisable on the later of 12 months from the closing of the IPO or upon completion of its initial Business Combination and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., Eastern Time, or earlier upon redemption or liquidation.

In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus is current. No warrant will be exercisable, and the Company will not be obligated to issue Class A ordinary shares upon exercise of a warrant unless Class A ordinary shares issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the share of Class A ordinary shares underlying such unit.

The Company may call the warrants for redemption (excluding the private warrants, and any outstanding Representative’s Warrants, and any warrants underlying units issued to the Sponsor, initial shareholders, officers, directors or their affiliates in payment of Working Capital Loans made to the Company), in whole and not in part, at a price of $0.01 per warrant:

●

at any time while the warrants are exercisable,

●

upon not less than 30 days’ prior written notice of redemption to each warrant holder,

●

if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period ending on the third trading business day prior to the notice of redemption to warrant holders, and

●

if, and only if, there is a current registration statement in effect with respect to the issuance of the Class A ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day until the date of redemption.

If the Company calls the warrants for redemption as described above, the management will have the option to require any holder that wishes to exercise its warrant to do so on a “cashless basis.” If the management takes advantage of this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of shares of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of shares of Class A ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” (defined below) over the exercise price of the warrants by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the Class A ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.

Rights — Except in cases where the Company is not the surviving company in a Business Combination, each holder of a right will automatically receive one-tenth (1/10) of a share of Class A ordinary shares upon consummation of the initial Business Combination, even if the holder of a right converted all shares held by him, her or it in connection with the initial Business Combination or an amendment to the Company’s memorandum and articles of association with respect to its pre-business combination activities. In the event that the Company will not be the surviving company upon completion of the initial Business Combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-tenth (1/10) of a share of Class A ordinary shares underlying each right upon consummation of the Business Combination. No additional consideration will be required to be paid by a holder of rights in order to receive his, her or its additional share of Class A ordinary shares upon consummation of an initial Business Combination. The shares issuable upon exchange of the rights will be freely tradable (except to the extent held by affiliates of the Company). If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of share of Class A ordinary shares will receive in the transaction on an as-converted into Class A ordinary shares basis.

The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of the Cayman Islands law. As a result, the holders of the rights must hold rights in multiples of 10 in order to receive shares for all of the holders’ rights upon closing of a Business Combination. If the Company is unable to complete an initial Business Combination within the required time period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of an initial Business Combination. Additionally, in no event will the Company be required to net cash settle the rights. Accordingly, the rights may expire worthless.

Note 9—Shareholders’ Equity

Preferred Shares — The Company is authorized to issue a total of 5,000,000 preferred shares at par value of $0.0001 each. At March 31, 2021, there were no preferred shares issued or outstanding.

Class A Ordinary Shares — The Company is authorized to issue a total of 500,000,000 Class A ordinary shares at par value of $0.0001 each. At March 31, 2021, there were 995,853 Class A ordinary shares issued and outstanding, excluding 8,558,147 Class A ordinary shares subject to possible redemption.

Class B Ordinary Shares — The Company is authorized to issue a total of 50,000,000 Class B ordinary shares at par value of $0.0001 each. In September 2020, the Sponsor subscribed 2,875,000 shares of the Company’s Class B ordinary shares for $25,000, or approximately $0.01 per share, in connection with formation. On November 9, 2020, the founders surrendered an aggregate of 287,500 Class B ordinary shares for no consideration, resulting in an aggregate of 2,587,500 Class B ordinary shares issued and outstanding. On December 24, 2020, 337,500 shares were forfeited as the over-allotment option was not exercised by the underwriters, resulting in an aggregate of 2,250,000 Class B ordinary shares issued and outstanding at March 31, 2021.

The Company’s initial shareholders have agreed not to transfer, assign or sell 50% its founder shares until the earlier to occur of (i) six months after the date of the consummation of the initial Business Combination or (ii) the date on which the closing price of the Company’s Class A ordinary shares equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after the initial Business Combination and the remaining 50% of the founder shares may not be transferred, assigned or sold until six months after the date of the consummation of the initial Business Combination, or earlier, in either case, if, subsequent to the initial Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the shareholders having the right to exchange their shares for cash, securities or other property.

The Class B ordinary shares will automatically convert into the Company’s Class A ordinary shares at the time of its initial Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the IPO and related to the closing of the initial Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all shares of Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of ordinary shares outstanding upon the completion of the IPO plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination or any private placement-equivalent units issued to the Sponsor or its affiliates upon conversion of loans made to the Company).

Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, with each share of ordinary shares entitling the holder to one vote.

Note 10— Fair Value Measurements

Investment Held in Trust Account

As of March 31, 2021, investment in the Company’s Trust Account consisted of $7,995 in cash and $91,545,039 in U.S. Treasury Securities. All of the U.S. Treasury Securities matured on May 13, 2021. The Company classifies its United States Treasury securities as held-to-maturity in accordance with FASB ASC 320 “Investments — Debt and Equity Securities”. Held-to-maturity treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts. The Company considers all investments with original maturities of more than three months but less than one year to be short-term investments. The carrying value approximates the fair value due to its short-term maturity. The carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities on March 31, 2021 are as follows:

	Amortized Cost and Carrying Value		Gross Unrealized Gains			Gross Unrealized Losses		Fair Value as of March 31, 2021
U.S. Money Market	$	7,995	$	-		$	-	$	7,995
U.S. Treasury Securities		91,545,039		(2,485	)		-		91,542,554
	$	91,553,034	$	(2,485	)	$	-	$	91,550,549

Warrant Liability

The Private Warrants and Representative’s Warrant are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting period. Changes in the fair value of the Warrants are recorded in the statement of operations each period.

The following table presents the Company’s fair value hierarchy for liabilities measured at fair value on a recurring basis as of March 31, 2021:

	Level 1		Level 2		Level 3		Total
Warrant liabilities:
Private Warrants		-		-		173,783		173,783
Representative’s Warrant						246,340		246,340
Total warrant liabilities	$	-	$	-	$	420,123	$	420,123

The Private Warrants and Representative’s Warrant were valued using a Montel Carlo simulation model, which is considered to be a Level 3 fair value measurement. Inherent in an options pricing model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.

There were no transfers between Levels 1, 2 or 3 during the three months ended March 31, 2021

The following table provides quantitative information regarding Level 3 fair value measurements for Private Warrants as of March 31, 2021 and December 31, 2020. The Representative’s Warrants were valued using similar information, except for strike price which is at $12

	March 31, 2021			December 31, 2020
Exercise price	$	11.50		$	11.50
Share price	$	9.99		$	10.24
Volatility		12.5	%		11.7	%
Expected life		5.67			5.91
Risk-free rate		1.08	%		0.49	%
Dividend yield		-	%		-	%

The following table presents a summary of the changes in the fair value of the Private Warrants and Representative’s Warrants, a Level 3 liability, measured on a recurring basis.

	Warrant Liability
Fair value, December 31, 2020	$	1,156,512
Gain on change in fair value (1)		(736,389	)
Fair value, March 31, 2021	$	420,123

(1)

Represents the non-cash gain on change in valuation of the Private Warrants and Representative’s Warrants and is included in Gain on change in fair value of warrant liability on the statement of operations.

Note 11—Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than the event disclosed below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities, those necessary to prepare for our Initial Public Offering and identifying a target company for our initial Business Combination. We do not expect to generate any operating revenues until after completion of our initial Business Combination. We generate non-operating income in the form of interest income on cash and cash equivalents held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as expenses as we conduct due diligence on prospective Business Combination candidates.

For the three months ended March 31, 2021, we had a net income of $626,634 consisting of formation and operating costs of $121,624, investment income of $11,869 and change in fair value in warrant liabilities of $736,389.

Liquidity and Capital Resources

As of March 31, 2021, the Company had cash outside the Trust Account of $727,773 available for working capital needs. All remaining cash held in the Trust Account is generally unavailable for the Company’s use, prior to an initial business combination, and is restricted for use either in a Business Combination or to redeem common stock. As of March 31, 2021 and December 31, 2020, none of the amount in the Trust Account was available to be withdrawn as described above.

The Company anticipates that the $727,773 outside of the Trust Account as of March 31, 2021, will be sufficient to allow the Company to operate for at least the next 12 months from the issuance of the financial statements, assuming that a Business Combination is not consummated during that time. Until consummation of its Business Combination, the Company will be using the funds not held in the Trust Account, and any additional Working Capital Loans (as defined in Note 4) from the initial stockholders, the Company’s officers and directors, or their respective affiliates (which is described in Note 6), for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the Business Combination.

Off-Balance Sheet Financing Arrangements

As of March 31, 2021, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. The Company has identified the following as its critical accounting policies:

Warrant Derivative Liabilities

We do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15.

We account for the Public Warrants, Private Warrants, Rights and Representative Warrants (as defined in Note 4,5 and 7) collectively (“Warrants”), as either equity or liability-classified instruments based on an assessment of the specific terms of the Warrants and the applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the Warrants meet all of the requirements for equity classification under ASC 815, including whether the Warrants are indexed to our own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of our control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of issuance of the Warrants and as of each subsequent quarterly period end date while the Warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, such warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, such warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of liability-classified warrants are recognized as a non-cash gain or loss on the statements of operations.

We account for the Private Warrants and Representative’s Warrant in accordance with ASC 815-40 under which the Warrants and FPAs do not meet the criteria for equity classification and must be recorded as liabilities. The fair value of the Private Warrants, Rights and Representative’s Warrant has been estimated using the Monte Carlo simulation model.

We evaluated the Public Warrants and Rights in accordance with ASC 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity,” and concluded that they met the criteria for equity classification and are required to be recorded as part a component of additional paid-in capital at the time of issuance.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not required for smaller reporting companies.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer (who serves as our principal executive officer) and Chief Financial Officer (who serves as our principal financial and accounting officer), to allow timely decisions regarding required disclosure.

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2021. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under November 12, 2020 audited closing balance sheet included in our current report on Form 8-K filed on November 18, 2020 the Exchange Act) were ineffective due to a deficiency in evaluating complex accounting issues which resulted in a revision of our December 31, 2020.

Revision of Previously Issued Financial Statements

We revised our prior position on accounting for warrants for November 12, 2020 financial statements to reclassify the Company’s private warrants and representative’s warrants. These non-cash adjustments to the financial statements do not impact the amounts previously reported for our cash and cash equivalents or total assets.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the quarter ending March 31, 2021, covered by this Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting, as the circumstances that led to the revision of our financial statements described in this Report had not yet been identified. Due solely to the events that led to our revision of our financial statements, management has identified a material weakness in internal controls related to the accounting for our private and representative warrants issued in connection with our initial public offering. In light of the revision of our financial statements, we plan to enhance our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our financial statements. Our plans at this time include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

As a “smaller reporting company”, we are not required to provide the information required by this Item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Use of Proceeds

On November 12, 2020, we consummated our initial public offering of 9,000,000 units. Each unit consists of one Class A ordinary share of the Company, par value $0.0001 per share, one right and one redeemable warrant of the Company, with each right entitling the holder thereof to receive one-tenth of one Class A ordinary share upon the consummation of an initial business combination, and with each warrant entitling the holder thereof to purchase one-half of one Class A ordinary share for $11.50 per whole share. The units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $90,000,000. On November 12, 2020, simultaneously with the consummation of our initial public offering, we completed the private sale of an aggregate of 479,000 units, 414,000 of which were sold to our sponsor and 65,000 of which were sold to I-Bankers Securities, Inc., the representative of the underwriters in our initial public offering, at a purchase price of $10.00 per private placement unit, generating gross proceeds of $4,790,000.

Following the closing of our initial public offering on November 12, 2020, $91,530,000 from the net proceeds of the sale of the units in our initial public offering and the sale of the private placement units was placed in a trust account established for the benefit of our public shareholders and maintained by Continental Stock Transfer & Trust Company, as trustee. The proceeds held in the trust account may be invested by the trustee only in U.S. government securities with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act.

There has been no material change in the planned use of the proceeds from our initial public offering and the private placement as is described in the Company’s final prospectus related to our initial public offering.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not Applicable.

Item 5. Other Information.

None.

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

No.		Description of Exhibit
10.1		Waiver Letter, dated January 5, 2021 by and among the Company, Christine Zhao, and I-Bankers Securities, Inc.⁽¹⁾
10.2		Termination Agreement, dated March 31, 2021, by and between the Company and American Physicians LLC⁽²⁾
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		XBRL Instance Document
101.CAL*		XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*		XBRL Taxonomy Extension Schema Document
101.DEF*		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document

*	Filed herewith.
**	Furnished.

(1)	Incorporated by reference to the Company’s Current Report on Form 8-K, filed with the SEC on January 5, 2021.

(2)

Incorporated by reference to the Company’s Current Report on Form 8-K, filed with the SEC on April 6, 2021.

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	EDOC ACQUISITION CORP.

Date: May 24, 2021	By:	/s/ Kevin Chen
	Name:	Kevin Chen
	Title:	Chief Executive Officer and Director
		(Principal Executive Officer)

Date: May 24, 2021	By:	/s/ Christine Zhao
	Name:	Christine Zhao
	Title:	Chief Financial Officer and Director
		(Principal Accounting and Financial Officer)

EX-31.1 2 f10q0321ex31-1_edocacq.htm CERTIFICATION

EXHIBIT 31.1

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Kevin Chen, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Edoc Acquisition Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942);

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: May 24, 2021	By:	/s/ Kevin Chen
		Kevin Chen
		Chief Executive Officer and Director
		(Principal Executive Officer)

EX-31.2 3 f10q0321ex31-2_edocacq.htm CERTIFICATION

EXHIBIT 31.2

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Christine Zhao, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Edoc Acquisition Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942);

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: May 24, 2021	By:	/s/ Christine Zhao
		Christine Zhao
		Chief Financial Officer and Director
		(Principal Financial and Accounting Officer)

EX-32.1 4 f10q0321ex32-1_edocacq.htm CERTIFICATION

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Edoc Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kevin Chen, Chief Executive Officer and Director of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 24, 2021

	/s/ Kevin Chen
	Name:	Kevin Chen
	Title:	Chief Executive Officer and Director (Principal Executive Officer)

EX-32.2 5 f10q0321ex32-2_edocacq.htm CERTIFICATION

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Edoc Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christine Zhao, Chief Financial Officer and Director of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 24, 2021

	/s/ Christine Zhao
	Name:	Christine Zhao
	Title:	Chief Financial Officer and Director
		(Principal Financial and Accounting Officer)

EX-101.INS 6 adoc-20210331.xml XBRL INSTANCE FILE 0001824884 2021-01-01 2021-03-31 0001824884 us-gaap:CommonClassAMember 2021-05-24 0001824884 us-gaap:CommonClassBMember 2021-05-24 0001824884 2021-03-31 0001824884 2020-12-31 0001824884 us-gaap:CommonClassAMember 2021-03-31 0001824884 us-gaap:CommonClassAMember 2020-12-31 0001824884 us-gaap:CommonClassBMember 2021-03-31 0001824884 us-gaap:CommonClassBMember 2020-12-31 0001824884 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001824884 us-gaap:RetainedEarningsMember 2020-12-31 0001824884 us-gaap:CommonClassAMember 2021-01-01 2021-03-31 0001824884 us-gaap:CommonClassBMember 2021-01-01 2021-03-31 0001824884 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001824884 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001824884 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001824884 us-gaap:RetainedEarningsMember 2021-03-31 0001824884 us-gaap:IPOMember 2020-11-01 2020-11-12 0001824884 us-gaap:IPOMember 2020-11-12 0001824884 us-gaap:PrivatePlacementMember 2020-11-01 2020-11-12 0001824884 2020-11-01 2020-11-12 0001824884 2020-11-12 0001824884 adoc:IBankerMember 2020-11-01 2020-11-12 0001824884 adoc:IBankerMember 2020-11-12 0001824884 us-gaap:IPOMember 2021-03-31 0001824884 adoc:ProposedPublicOfferingsMember 2021-01-01 2021-03-31 0001824884 adoc:MarketableSecuritiesMember 2021-03-31 0001824884 us-gaap:IPOMember 2021-01-01 2021-03-31 0001824884 2020-01-01 2020-12-31 0001824884 adoc:SponsorMember 2021-01-01 2021-03-31 0001824884 us-gaap:PrivatePlacementMember 2021-01-01 2021-03-31 0001824884 adoc:FounderSharesMember 2020-09-01 2020-09-30 0001824884 us-gaap:CommonClassBMember 2020-09-01 2020-09-30 0001824884 us-gaap:CommonClassBMember 2020-09-30 0001824884 adoc:FounderSharesMember 2020-11-09 0001824884 us-gaap:OverAllotmentOptionMember 2020-12-24 0001824884 adoc:UnsecuredPromissoryNoteMember 2020-09-30 0001824884 2020-11-09 2020-11-09 0001824884 us-gaap:CommonClassAMember 2020-11-01 2020-11-12 0001824884 us-gaap:CommonClassAMember us-gaap:WarrantMember 2021-01-01 2021-03-31 0001824884 adoc:ClassAOrdinarySharesMember 2021-03-31 0001824884 us-gaap:CommonClassBMember 2020-09-30 2020-09-30 0001824884 2020-12-24 2020-12-24 0001824884 us-gaap:OverAllotmentOptionMember 2021-03-31 0001824884 us-gaap:MoneyMarketFundsMember 2021-03-31 0001824884 us-gaap:MoneyMarketFundsMember 2021-01-01 2021-03-31 0001824884 us-gaap:USTreasurySecuritiesMember 2021-03-31 0001824884 us-gaap:USTreasurySecuritiesMember 2021-01-01 2021-03-31 0001824884 us-gaap:FairValueInputsLevel1Member adoc:PrivateWarrantsMember 2021-03-31 0001824884 us-gaap:FairValueInputsLevel2Member adoc:PrivateWarrantsMember 2021-03-31 0001824884 us-gaap:FairValueInputsLevel3Member adoc:PrivateWarrantsMember 2021-03-31 0001824884 adoc:PrivateWarrantsMember 2021-03-31 0001824884 us-gaap:FairValueInputsLevel3Member adoc:RepresentativesWarrantMember 2021-03-31 0001824884 adoc:RepresentativesWarrantMember 2021-03-31 0001824884 us-gaap:FairValueInputsLevel1Member adoc:TotalWarrantLiabilitiesMember 2021-03-31 0001824884 us-gaap:FairValueInputsLevel2Member adoc:TotalWarrantLiabilitiesMember 2021-03-31 0001824884 us-gaap:FairValueInputsLevel3Member adoc:TotalWarrantLiabilitiesMember 2021-03-31 0001824884 adoc:TotalWarrantLiabilitiesMember 2021-03-31 0001824884 2020-10-01 2020-12-31 0001824884 adoc:WarrantLiabilityMember 2020-12-31 0001824884 adoc:WarrantLiabilityMember 2021-01-01 2021-03-31 0001824884 adoc:WarrantLiabilityMember 2021-03-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure Represents the non-cash gain on change in valuation of the Private Warrants and Representative’s Warrants and is included in Gain on change in fair value of warrant liability on the statement of operations. false --12-31 Q1 2021 2021-03-31 10-Q 0001824884 No true false 001-39689 Non-accelerated Filer E9 Yes Edoc Acquisition Corp. true true 9554000 2250000

727773

1000730

311831

97498

1047599

1098228

91550549

91538680

92590153

92636908

133680

53680

17000

133680

70680

420123

1156512

553803

1227192

87036350

86409715

8558147 8558147

10.17

0.0001

5000000

105

0.0001

500000000

995853

1057469

995853

1057469

225

0.0001

50000000

2250000

4938340

5564969

61336

-565298

5000000

5000001

92590153

92636908

121624

-121624

11869

-736389

748258

626634

8496531 0.00

3307469

0.19

1057469

105

2250000

225

5564969

-565298

626634

-61616 -6 -626629 -626635

995853

2250000

225

4938340

61336

11869

214333

-17000

80000

-272957

1000730

727773

626635

Note 1—Description of Organization, Business Operations and Basis of Presentation EDOC Acquisition Corp. (the “Company”) was incorporated in the Cayman Islands on August 20, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). While the Company may pursue an acquisition opportunity in any industry or geographic region, the Company intends to focus on businesses primarily operating in the health care and health care provider space in North America and Asia-Pacific. The Company has selected December 31 as its fiscal year end. As of March 31, 2021, the Company had not yet commenced any operations. All activity through March 31, 2021, relates to the Company’s formation and the Initial Public Offering (“IPO”) described below. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. The Company’s sponsor is American Physicians LLC (the “Sponsor”). Financing The registration statement for the Company’s initial public offering was declared effective on November 9, 2020 (the “Effective Date”). On November 12, 2020, the Company consummated the initial public offering of 9,000,000 units (each, a “Unit” and collectively, the “Units”) at $10.00 per Unit (the “Initial Public Offering” or “IPO”), which is discussed in Note 3. Simultaneously with the closing of the IPO, the Company consummated the sale of 479,000 private placement units (“Private Unit)” and collectively, the “Private Units”), at a price of $10.00 per unit. Of the 479,000 private placement units, 65,000 units, or the “representative units” were purchased by I-Banker (and/or its designees). In addition, the Company’s sponsor agreed, pursuant to a letter agreement to purchase up to 3,750,000 of the Company’s rights in the open market at a market price not to exceed $0.20 per right. I-Bankers also agreed to purchase up to 1,250,000 of the Company’s rights in the open market at a market price not to exceed $0.20 per right, which is discussed in Note 4. Transaction costs of the IPO amounted to $3,246,381, consisting of $1,575,000 of cash underwriting fees, the fair value of the representative’s warrants of $424,270, the fair value of representative’s shares $ 653,250 and $593,861 of other cash offering costs. Trust Account Following the closing of the IPO on November 12, 2020, $91,530,000 ($10.17 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (“Trust Account”) and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, until the earlier of: (i) the completion of a Business Combination, (ii) the redemption of any public shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation, and (iii) the redemption of the Company’s public shares if the Company is unable to complete the initial Business Combination within 24 months from the closing of the IPO (the “Combination Period”), subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholder. Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes and excluding the amount of any deferred underwriting discount held in trust) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). Upon the closing of the Proposed Public Offering, an amount equal to at least $10.00 per Unit sold in the Proposed Public Offering, including the proceeds from the sale of the Private Placement Warrants to the Sponsor, was placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. government securities,” within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company will provide holders of the Company’s outstanding shares of Class A ordinary shares, par value $0.0001 per share, sold in the IPO (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares (as defined below) upon the completion of the initial business combination either (i) in connection with a shareholder meeting called to approve the initial business combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial business combination or conduct a tender offer will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially approximately $10.17 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The ordinary shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the Proposed Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company will have 12 months (or up to 18 months if the Company extends the period of time) from the closing of the Proposed Public Offering to consummate a Business Combination (the “Combination Period”). However, if the Company is unable to complete a Business Combination within the Combination Period, the Company will redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the trust account, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to the Company to pay its franchise and income taxes, divided by the number of then outstanding public shares, subject to applicable law and as further described in registration statement, and then seek to dissolve and liquidate. The Sponsor, officers and directors and Representative (defined in Note 6) have agreed to (i) waive their redemption rights with respect to their founder shares, private shares, and public shares in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to their founder shares, private shares, and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation, and (iii) waive their rights to liquidating distributions from the trust account with respect to their founder shares and private shares if the Company fails to complete the initial business combination within the Combination Period. The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.17 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.17 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of this offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Company’s Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might results from the outcome of this uncertainty. Liquidity As of March 31, 2021, the Company had cash outside the Trust Account of $727,773 available for working capital needs. All remaining cash held in the Trust Account are generally unavailable for the Company’s use, prior to an initial business combination, and is restricted for use either in a Business Combination or to redeem ordinary shares. As of March 31, 2021 and December 31, 2020, none of the amount in the Trust Account was available to be withdrawn as described above. Through March 31, 2021, the Company’s liquidity needs were satisfied through receipt of $25,000 from the sale of the founder shares and the remaining net proceeds from the IPO and the sale of Private Placement Warrants. The Company anticipates that the $727,773 outside of the Trust Account as of March 31, 2021, will be sufficient to allow the Company to operate for at least the next 12 months from the issuance of the financial statements, assuming that a Business Combination is not consummated during that time. Until consummation of its Business Combination, the Company will be using the funds not held in the Trust Account, and any additional Working Capital Loans (as defined in Note 6) from the initial stockholders, the Company’s officers and directors, or their respective affiliates (which is described in Note 6), for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the Business Combination. The Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the Company’s estimates of the costs of undertaking in-depth due diligence and negotiating business combination is less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the business combination. Moreover, the Company will need to raise additional capital through loans from its Sponsor, officers, directors, or third parties. None of the Sponsor, officers or directors are under any obligation to advance funds to, or to invest in, the Company. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of its business plan, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. Risks and Uncertainties On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the “COVID-19 outbreak”). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve. The impact of the COVID-19 outbreak on the Company’s financial position will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of the COVID-19 outbreak on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s financial position may be materially adversely affected. Additionally, the Company’s ability to complete an initial business combination may be materially adversely affected due to significant governmental measures being implemented to contain the COVID-19 outbreak or treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit the Company’s ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate an initial business combination in a timely manner. The Company’s ability to consummate an initial business combination may also be dependent on the ability to raise additional equity and debt financing, which may be impacted by the COVID-19 outbreak and the resulting market downturn.

9000000

10.00

479000 65000 3750000 0.20 1250000 0.20

3246381

1575000

424270

653250

593861

0.80

0.50

10.00

5000001

1.00 The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.17 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.17 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of this offering against certain liabilities, including liabilities under the Securities Act. 727773

25000

727773

Note 2—Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statements of the Company is presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are necessary to present fairly the financial position, and the results of its operations and its cash flows. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Form 10-K for the period from August 20, 2020 (inception) through December 31, 2020 as filed with the SEC on May 24, 2021, which contains the audited financial statements and notes thereto. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of March 31, 2021, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Use of Estimates The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting period and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. Investment Held in Trust Account At March 31, 2021, the Trust Account had $91,542,554 held in marketable securities. During period January 1, 2021 to March 31, 2021, the Company did not withdraw any of interest income from the Trust Account to pay its tax obligations. Fair Value Measurements The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet. Derivative warrant liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company accounts for its 479,000 Private Warrants and 450,000 Representative’s Warrants issued in connection with its Initial Public Offering as derivative warrant liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued by the Company in connection with the Public Offering and Private Placement has been estimated using Monte-Carlo simulations at each measurement date. Offering Costs Associated with IPO The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering and that were charged to shareholders’ equity upon the completion of the IPO. Accordingly, on December 31, 2020, offering costs totaling $3,246,381 have been charged to shareholders’ equity (consisting of $1,575,000 of underwriting fee, the fair value of the representative’s warrants of $424,270, the fair value of representative’s shares $653,250 and $593,861 of other cash offering costs). Class A Ordinary shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2021, 8,558,147 shares of Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Net Loss Per Ordinary Share Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for each of the periods. The calculation of diluted loss per ordinary share does not consider the effect of the warrants and rights issued in connection with the (i) IPO since the exercise of the warrants and rights are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants and rights are exercisable for 6,137,400 shares of Class A ordinary shares in the aggregate. <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months ended March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Ordinary shares subject to possible redemption</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td>Numerator: Net income allocable to Class A ordinary shares subject to possible redemption</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; text-indent: -9pt; padding-left: 27pt">Amortized Interest income on Treasury securities held in trust</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10,632</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 27pt">Less: interest available to be withdrawn for payment of taxes</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 0.5in">Net income allocable to Class A ordinary shares subject to possible redemption</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">10,632</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Denominator: Weighted Average Redeemable Class A ordinary shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 27pt">Redeemable Class A Ordinary shares, Basic and Diluted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,496,531</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Basic and Diluted net income per share, Redeemable Class A Ordinary shares</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt">Non-Redeemable Ordinary shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Numerator: Net Income minus Redeemable Net Earnings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 27pt">Net Income</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">626,634</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 27pt">Redeemable Net Loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,632</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 0.5in">Non-Redeemable Net Income</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">616,002</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 0.25in">Denominator: Weighted Average Non-Redeemable Ordinary shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 27pt">Basic and diluted weighted average shares outstanding, ordinary shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,307,469</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 0.5in">Basic and diluted net loss per share, ordinary shares</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.19</td><td style="text-align: left"> </td></tr> </table> Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent Accounting Standards The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

250000

91542554

479000 450000 Offering Costs Associated with IPO The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering and that were charged to shareholders’ equity upon the completion of the IPO. Accordingly, on December 31, 2020, offering costs totaling $3,246,381 have been charged to shareholders’ equity (consisting of $1,575,000 of underwriting fee, the fair value of the representative’s warrants of $424,270, the fair value of representative’s shares $653,250 and $593,861 of other cash offering costs).

3246381

1575000 424270 593861

6137400

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months ended March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Ordinary shares subject to possible redemption</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td>Numerator: Net income allocable to Class A ordinary shares subject to possible redemption</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; text-indent: -9pt; padding-left: 27pt">Amortized Interest income on Treasury securities held in trust</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10,632</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 27pt">Less: interest available to be withdrawn for payment of taxes</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 0.5in">Net income allocable to Class A ordinary shares subject to possible redemption</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">10,632</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Denominator: Weighted Average Redeemable Class A ordinary shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 27pt">Redeemable Class A Ordinary shares, Basic and Diluted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,496,531</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Basic and Diluted net income per share, Redeemable Class A Ordinary shares</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt">Non-Redeemable Ordinary shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Numerator: Net Income minus Redeemable Net Earnings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 27pt">Net Income</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">626,634</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 27pt">Redeemable Net Loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,632</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 0.5in">Non-Redeemable Net Income</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">616,002</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 0.25in">Denominator: Weighted Average Non-Redeemable Ordinary shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 27pt">Basic and diluted weighted average shares outstanding, ordinary shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,307,469</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 0.5in">Basic and diluted net loss per share, ordinary shares</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.19</td><td style="text-align: left"> </td></tr> </table>

10632

8496531 0.00

626634

-10632

616002

3307469

0.19

9000000

10.00

Each unit consists of one share of Class A ordinary shares, one-half warrant to purchase one share of Class A ordinary shares (“Public Warrants”), and one right (“Rights”). Each Public Warrant will entitle the holder to purchase one share of Class A ordinary shares at a price of $11.50 per share, subject to adjustment.

P5Y

414000

65000

479000

10.00

4790000

2875000

25000

0.01

287500

2587500 337500 337500

300000

177591 1500000

10.00

10000

75000 0.01 653250

450000

The Company estimated the fair value of the Representative’s Warrant is $424,270 using the Monte Carlo simulation model. The fair value of the Representative’s Warrant to granted to the underwriters is estimated as of the date of grant using the following assumptions: (1) expected volatility of 24.1%, (2) risk-free interest rate of 0.60% and (3) expected life of 6.05 years. The expected volatility was determined by the Company based on the historical volatilities of a set of comparative special purpose acquisition companies (“SPAC”), and the risk-fee interest rate was determined by reference to the U.S. Treasury yield curve in effect for time period equals to the expected life of the Representative’s Warrant.

0.0175 1575000 0.0275

2475000

The Sponsor has agreed to enter into an agreement in accordance with the guidelines of Rule 10b5-1 under the Exchange Act, to place limit orders, through an independent broker-dealer registered under Section 15 of the Exchange Act which is not affiliated with the Company nor part of the underwriting or selling group, to purchase an aggregate of up to 3,750,000 of the Company’s rights in the open market at market prices, and not to exceed $0.20 per right during the period commencing on the later of (i) the date separate trading of the rights commences or (ii) sixty calendar days after the end of the “restricted period” under Regulation M, continuing until the date that is the earlier of (a) twelve (12) months from the date of the IPO and (b) the date that the Company announces that it has entered into a definitive agreement in connection with its initial Business Combination, or earlier in certain circumstances as described in the limit order agreement. The limit orders will require the Sponsor to purchase any rights offered for sale (and not purchased by another investor) at or below a price of $0.20, until the earlier of (x) the expiration of the buyback period or (y) the date such purchases reach 3,750,000 rights in total. 1250000 0.20 Note 8 -Warrants and Rights Warrants —Each whole warrant entitles the holder to purchase one share of the Company’s Class A ordinary shares at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.50 per share of Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Company’s Sponsor or its affiliates, without taking into account any founder shares held by the Company’s Sponsor or its affiliates, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Value, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the Market Value. The warrants will become exercisable on the later of 12 months from the closing of the IPO or upon completion of its initial Business Combination and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., Eastern Time, or earlier upon redemption or liquidation. In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus is current. No warrant will be exercisable, and the Company will not be obligated to issue Class A ordinary shares upon exercise of a warrant unless Class A ordinary shares issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the share of Class A ordinary shares underlying such unit. The Company may call the warrants for redemption (excluding the private warrants, and any outstanding Representative’s Warrants, and any warrants underlying units issued to the Sponsor, initial shareholders, officers, directors or their affiliates in payment of Working Capital Loans made to the Company), in whole and not in part, at a price of $0.01 per warrant: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">at any time while the warrants are exercisable,</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify">●</td> <td style="text-align: justify">upon not less than 30 days’ prior written notice of redemption to each warrant holder,</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify">●</td> <td style="text-align: justify">if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period ending on the third trading business day prior to the notice of redemption to warrant holders, and</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify">●</td> <td style="text-align: justify">if, and only if, there is a current registration statement in effect with respect to the issuance of the Class A ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day until the date of redemption.</td></tr> </table> If the Company calls the warrants for redemption as described above, the management will have the option to require any holder that wishes to exercise its warrant to do so on a “cashless basis.” If the management takes advantage of this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of shares of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of shares of Class A ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” (defined below) over the exercise price of the warrants by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the Class A ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. Rights — Except in cases where the Company is not the surviving company in a Business Combination, each holder of a right will automatically receive one-tenth (1/10) of a share of Class A ordinary shares upon consummation of the initial Business Combination, even if the holder of a right converted all shares held by him, her or it in connection with the initial Business Combination or an amendment to the Company’s memorandum and articles of association with respect to its pre-business combination activities. In the event that the Company will not be the surviving company upon completion of the initial Business Combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-tenth (1/10) of a share of Class A ordinary shares underlying each right upon consummation of the Business Combination. No additional consideration will be required to be paid by a holder of rights in order to receive his, her or its additional share of Class A ordinary shares upon consummation of an initial Business Combination. The shares issuable upon exchange of the rights will be freely tradable (except to the extent held by affiliates of the Company). If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of share of Class A ordinary shares will receive in the transaction on an as-converted into Class A ordinary shares basis. The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of the Cayman Islands law. As a result, the holders of the rights must hold rights in multiples of 10 in order to receive shares for all of the holders’ rights upon closing of a Business Combination. If the Company is unable to complete an initial Business Combination within the required time period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of an initial Business Combination. Additionally, in no event will the Company be required to net cash settle the rights. Accordingly, the rights may expire worthless. Each whole warrant entitles the holder to purchase one share of the Company’s Class A ordinary shares at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.50 per share of Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Company’s Sponsor or its affiliates, without taking into account any founder shares held by the Company’s Sponsor or its affiliates, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Value, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the Market Value. P5Y The Company may call the warrants for redemption (excluding the private warrants, and any outstanding Representative’s Warrants, and any warrants underlying units issued to the Sponsor, initial shareholders, officers, directors or their affiliates in payment of Working Capital Loans made to the Company), in whole and not in part, at a price of $0.01 per warrant: ●at any time while the warrants are exercisable, ● upon not less than 30 days’ prior written notice of redemption to each warrant holder, ● if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period ending on the third trading business day prior to the notice of redemption to warrant holders, and ● if, and only if, there is a current registration statement in effect with respect to the issuance of the Class A ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day until the date of redemption.

500000000

0.0001

995853

8558147

2875000

25000 0.01 287500

2587500

337500

2250000

995853

Note 10— Fair Value Measurements Investment Held in Trust Account As of March 31, 2021, investment in the Company’s Trust Account consisted of $7,995 in cash and $91,545,039 in U.S. Treasury Securities. All of the U.S. Treasury Securities matured on May 13, 2021. The Company classifies its United States Treasury securities as held-to-maturity in accordance with FASB ASC 320 “Investments — Debt and Equity Securities”. Held-to-maturity treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts. The Company considers all investments with original maturities of more than three months but less than one year to be short-term investments. The carrying value approximates the fair value due to its short-term maturity. The carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities on March 31, 2021 are as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortized Cost and Carrying Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Unrealized Gains</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Unrealized Losses</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Value as of March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left; text-indent: -9pt; padding-left: 9pt">U.S. Money Market</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,995</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">         -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,995</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">U.S. Treasury Securities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">91,545,039</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,485</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">91,542,554</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">91,553,034</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,485</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">91,550,549</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> Warrant Liability The Private Warrants and Representative’s Warrant are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting period. Changes in the fair value of the Warrants are recorded in the statement of operations each period. The following table presents the Company’s fair value hierarchy for liabilities measured at fair value on a recurring basis as of March 31, 2021:  <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warrant liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 10pt; width: 52%; text-align: left">Private Warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">-  </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">-  </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">173,783</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">173,783</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Representative’s Warrant</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">246,340</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">246,340</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total warrant liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-  </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-  </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">420,123</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">420,123</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> The Private Warrants and Representative’s Warrant were valued using a Montel Carlo simulation model, which is considered to be a Level 3 fair value measurement. Inherent in an options pricing model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero. There were no transfers between Levels 1, 2 or 3 during the three months ended March 31, 2021 The following table provides quantitative information regarding Level 3 fair value measurements for Private Warrants as of March 31, 2021 and December 31, 2020. The Representative’s Warrants were valued using similar information, except for strike price which is at $12 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-indent: -9pt; padding-left: 9pt">Exercise price</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11.50</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11.50</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt">Share price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9.99</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">10.24</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt">Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.5</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11.7</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Expected life</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.67</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.91</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Risk-free rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.08</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.49</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left">%</td></tr> </table> The following table presents a summary of the changes in the fair value of the Private Warrants and Representative’s Warrants, a Level 3 liability, measured on a recurring basis. <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrant Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-indent: -9pt; padding-left: 9pt">Fair value, December 31, 2020</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,512</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Gain on change in fair value (1)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(736,389</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Fair value, March 31, 2021</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">420,123</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Represents the non-cash gain on change in valuation of the Private Warrants and Representative’s Warrants and is included in Gain on change in fair value of warrant liability on the statement of operations.</td> </tr></table>

7995

91545039

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortized Cost and Carrying Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Unrealized Gains</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Unrealized Losses</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Value as of March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left; text-indent: -9pt; padding-left: 9pt">U.S. Money Market</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,995</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">         -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,995</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">U.S. Treasury Securities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">91,545,039</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,485</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">91,542,554</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">91,553,034</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,485</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">91,550,549</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>

7995

91545039

2485

91542554

91553034

2485

91550549

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warrant liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 10pt; width: 52%; text-align: left">Private Warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">-  </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">-  </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">173,783</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">173,783</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Representative’s Warrant</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">246,340</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">246,340</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total warrant liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-  </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-  </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">420,123</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">420,123</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table>

173783

246340

420123

11.50 11.50 9.99 10.24 0.125 0.117 P5Y244D P5Y332D 0.0108 0.0049

1156512

-736389

420123

EX-101.SCH 7 adoc-20210331.xsd XBRL SCHEMA FILE 001 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Statement of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Statement Of Changes In Shareholders’ Equity (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Statement Of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Description of Organization, Business Operations and Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Initial Public Offering link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Private Placement link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Warrants and Rights link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Shareholders' Equity link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Description of Organization, Business Operations and Basis of Presentation (Details) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per ordinary share link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Initial Public Offering (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Private Placement (Details) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Warrants and Rights (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Shareholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Fair Value Measurements (Details) - Schedule of carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Fair Value Measurements (Details) - Schedule of fair value measured on recurring basis link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Fair Value Measurements (Details) - Schedule of fair value of warrant liabilities link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 adoc-20210331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 adoc-20210331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 adoc-20210331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Statement of Financial Position [Abstract] Total current assets Total Assets Total current liabilities Total Liabilities Total Shareholders’ Equity Balance Balance Total Liabilities and Shareholders’ Equity Income Statement [Abstract] Loss from operations Total other income Net Income Net income Net Income Statement of Stockholders' Equity [Abstract] Balance (in Shares) Balance (in Shares) Equity Components [Axis] Statement of Cash Flows [Abstract] Net cash used in operating activities Net change in cash Cash, beginning of the period Cash, end of period Accounting Policies [Abstract] Schedule of basic and diluted loss per ordinary share [Abstract] Initial Public Offering [Abstract] Private Placement Disclosure [Abstract] Related Party Transactions [Abstract] Commitments and Contingencies Disclosure [Abstract] Warrants And Rights [Abstract] Stockholders' Equity Note [Abstract] Fair Value Disclosures [Abstract] Schedule of carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities [Abstract] Cash and Cash Equivalents [Axis] Schedule of fair value measured on recurring basis [Abstract] Sale of Stock [Axis] Fair Value Hierarchy and NAV [Axis] Schedule of quantitative information regarding Level 3 fair value measurements [Abstract] Schedule of fair value of warrant liabilities [Abstract] Fair value, December 31, 2020 Fair value, March 31, 2021 Subsequent Events [Abstract] Amendment Flag Current Fiscal Year End Date Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date Document Type Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Current Reporting Status Entity Emerging Growth Company Entity Ex Transition Period Entity File Number Entity Filer Category Entity Incorporation, State or Country Code Entity Interactive Data Current Entity Registrant Name Entity Shell Company Entity Small Business Assets: Current assets: Cash Prepaid expenses Cash and marketable securities held in Trust Account Liabilities and Shareholders’ Equity: Current liabilities: Accounts payable and accrued expenses Due to related party Warrant liability Total warrant liabilities Commitments and Contingencies Class A ordinary shares subject to possible redemption, 8,558,147 shares at $10.17 Ordinary shares, subject to possible redemption Shares subject to possible redemption (in Shares) Ordinary share subject to possible redemption, per share redemption value (in Dollars per share) Shareholders’ Equity: Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding Preferred stock par value (in Dollars per share) Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Ordinary shares Ordinary shares, par value (in Dollars per share) Ordinary shares, shares authorized Ordinary shares, shares issued Ordinary shares, shares outstanding Additional paid-in capital Accumulated surplus (deficit) Formation and operating costs Other income (expenses): Amortized interest on marketable securities held in Trust Account Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption (in Shares) Basic and diluted net income per share, Class A ordinary shares subject to possible redemption (in Dollars per share) Basic and diluted weighted average shares outstanding, ordinary shares (in Shares) Basic and diluted net loss per share, ordinary shares (in Dollars per share) Class A ordinary shares subject to possible redemption Class A ordinary shares subject to possible redemption (in Shares) Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Change in Fair Value of Warrant Liability Change in fair value of warrants Changes in operating assets and liabilities: Due to related party Accounts payable and accrued expenses Supplemental disclosure of cash flow information: Non-cash investing and financing transactions: Change in value of Class A ordinary shares subject to possible redemption Amortized interest on cash and Treasury securities held in Trust Account Prepaid expenses Class A ordinary shares Class A Ordinary Shares [Member] Class B ordinary shares Class B Ordinary Shares [Member] Class B ordinary shares [Member] Additional Paid-In Capital Accumulated Deficit Description of Organization, Business Operations and Basis of Presentation Summary of Significant Accounting Policies Schedule of basic and diluted loss per ordinary share Ordinary shares subject to possible redemption Numerator: Net income allocable to Class A ordinary shares subject to possible redemption Amortized Interest income on Treasury securities held in trust Less: interest available to be withdrawn for payment of taxes Net income allocable to Class A ordinary shares subject to possible redemption Denominator: Weighted Average Redeemable Class A ordinary shares Redeemable Class A Ordinary shares, Basic and Diluted (in Shares) Basic and Diluted net income per share, Redeemable Class A Ordinary shares Non-Redeemable Ordinary shares Numerator: Net Income minus Redeemable Net Earnings Net Income Redeemable Net Loss Non-Redeemable Net Income Denominator: Weighted Average Non-Redeemable Ordinary shares Basic and diluted weighted average shares outstanding, ordinary shares (in Shares) Basic and diluted net loss per share, ordinary shares (in Dollars per share) Initial Public Offering Private Placement Related Party Transactions Commitments and Contingencies Warrants and Rights Shareholders' Equity Fair Value Measurements Schedule of carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities Amortized Cost and Carrying Value Gross Unrealized Losses Fair Value Schedule of fair value measured on recurring basis Schedule of quantitative information regarding Level 3 fair value measurements Exercise price (in Dollars per share) Share price (in Dollars per share) Volatility Expected life Risk-free rate Dividend yield Schedule of fair value of warrant liabilities Gain on change in fair value Subsequent Events Gross Unrealized Gains U.S. Money Market [Member] U.S. Treasury Securities [Member] Private Warrants [Member] Representative’s Warrant [Member] Total warrant liabilities [Member] Level 1 [Member] Level 2 [Member] Level 3 [Member] Warrant Liability [Member] Related Party [Axis] Debt Instrument [Axis] Sale of stock (in Shares) Sale of stock Aggregate shares purchase Issuance of sponsor shares Sale of stock price per share (in Dollars per share) Sale of stock price per share Issuance of price per share (in Dollars per share) Private placement units (in Shares) Number of units (in Shares) Number of purchase share (in Shares) Market price per right (in Dollars per share) Transaction cost Cash underwriting fee Fair value of warrants Other cash Other offering cost Initial public offering, description Aggregate fair market value, percentage Outstanding voting securities percentage Trust account per public share (in Dollars per share) Business combination description Net tangible assets least Redeem public shares, percentage Business combination agreement, description Working capital Capital contribution Cash Foreign financial institutions man dated deposits Trust account held in marketable securities Held in trust account cash Common stock warrants issued (in Shares) EX-101.PRE 11 adoc-20210331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Mar. 31, 2021	May 24, 2021
Document Information Line Items
Entity Registrant Name	Edoc Acquisition Corp.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Central Index Key	0001824884
Entity Current Reporting Status	No
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Mar. 31, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
Entity File Number	001-39689
Entity Incorporation, State or Country Code	E9
Entity Interactive Data Current	Yes
Class A ordinary shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		9,554,000
Class B ordinary shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		2,250,000

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash	$ 727,773	$ 1,000,730
Prepaid expenses	311,831	97,498
Total current assets	1,047,599	1,098,228
Cash and marketable securities held in Trust Account	91,550,549	91,538,680
Total Assets	92,590,153	92,636,908
Current liabilities:
Accounts payable and accrued expenses	133,680	53,680
Due to related party		17,000
Total current liabilities	133,680	70,680
Warrant liability	420,123	1,156,512
Total Liabilities	553,803	1,227,192
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, 8,558,147 shares at $10.17	87,036,350	86,409,715
Shareholders’ Equity:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Additional paid-in capital	4,938,340	5,564,969
Accumulated surplus (deficit)	61,336	(565,298)
Total Shareholders’ Equity	5,000,000	5,000,001
Total Liabilities and Shareholders’ Equity	92,590,153	92,636,908
Class A ordinary shares
Shareholders’ Equity:
Ordinary shares	99	105
Total Shareholders’ Equity	99	105
Class B ordinary shares
Shareholders’ Equity:
Ordinary shares	225	225
Total Shareholders’ Equity	$ 225	$ 225

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets (Parentheticals) - $ / shares	Mar. 31, 2021	Dec. 31, 2020
Preferred stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Class A ordinary shares
Ordinary shares, subject to possible redemption	8,558,147	8,558,147
Ordinary share subject to possible redemption, per share redemption value (in Dollars per share)	$ 10.17	$ 10.17
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	500,000,000	500,000,000
Ordinary shares, shares issued	995,853	1,057,469
Ordinary shares, shares outstanding	995,853	1,057,469
Class B ordinary shares
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	50,000,000	50,000,000
Ordinary shares, shares issued	2,250,000	2,250,000
Ordinary shares, shares outstanding	2,250,000	2,250,000

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Statement of Operations (Unaudited)	3 Months Ended
Condensed Statement of Operations (Unaudited)	Mar. 31, 2021 USD ($) $ / shares shares
Income Statement [Abstract]
Formation and operating costs	$ 121,624
Loss from operations	(121,624)
Amortized interest on marketable securities held in Trust Account	11,869
Change in fair value of warrants	736,389
Total other income	748,258
Net Income	$ 626,634
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption (in Shares) \| shares	8,496,531
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption (in Dollars per share) \| $ / shares	$ 0.00
Basic and diluted weighted average shares outstanding, ordinary shares (in Shares) \| shares	3,307,469
Basic and diluted net loss per share, ordinary shares (in Dollars per share) \| $ / shares	$ 0.19

XML 16 R5.htm IDEA: XBRL DOCUMENT

Condensed Statement Of Changes In Shareholders’ Equity (Unaudited) - 3 months ended Mar. 31, 2021 - USD ($)	Class A ordinary shares	Class B ordinary shares	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2020	$ 105	$ 225	$ 5,564,969	$ (565,298)	$ 5,000,001
Balance (in Shares) at Dec. 31, 2020	1,057,469	2,250,000
Net income				626,634	626,634
Class A ordinary shares subject to possible redemption	$ (6)		(626,629)		(626,635)
Class A ordinary shares subject to possible redemption (in Shares)	(61,616)
Balance at Mar. 31, 2021	$ 99	$ 225	$ 4,938,340	$ 61,336	$ 5,000,000
Balance (in Shares) at Mar. 31, 2021	995,853	2,250,000

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References + Details

XML 17 R6.htm IDEA: XBRL DOCUMENT

Condensed Statement Of Cash Flows (Unaudited)	3 Months Ended
Condensed Statement Of Cash Flows (Unaudited)	Mar. 31, 2021 USD ($)
Cash flows from operating activities:
Net Income	$ 626,634
Adjustments to reconcile net loss to net cash used in operating activities:
Amortized interest on cash and Treasury securities held in Trust Account	(11,869)
Change in Fair Value of Warrant Liability	(736,389)
Changes in operating assets and liabilities:
Prepaid expenses	(214,333)
Due to related party	(17,000)
Accounts payable and accrued expenses	80,000
Net cash used in operating activities	(272,957)
Net change in cash	(272,957)
Cash, beginning of the period	1,000,730
Cash, end of period	727,773
Non-cash investing and financing transactions:
Change in value of Class A ordinary shares subject to possible redemption	$ 626,635

XML 18 R7.htm IDEA: XBRL DOCUMENT

Description of Organization, Business Operations and Basis of Presentation

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Description of Organization, Business Operations and Basis of Presentation

Note 1—Description of Organization, Business Operations and Basis of Presentation

The Company’s sponsor is American Physicians LLC (the “Sponsor”).

Financing

Trust Account

Business Combination

Risks and Uncertainties

Liquidity

Risks and Uncertainties

XML 19 R8.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2—Summary of Significant Accounting Policies

Basis of Presentation

Emerging Growth Company

Concentration of Credit Risk

Use of Estimates

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.

Investment Held in Trust Account

Fair Value Measurements

Derivative warrant liabilities

Offering Costs Associated with IPO

Class A Ordinary shares Subject to Possible Redemption

Net Loss Per Ordinary Share

	For the Three Months ended March 31, 2021
Ordinary shares subject to possible redemption
Numerator: Net income allocable to Class A ordinary shares subject to possible redemption
Amortized Interest income on Treasury securities held in trust	$	10,632
Less: interest available to be withdrawn for payment of taxes		-
Net income allocable to Class A ordinary shares subject to possible redemption	$	10,632
Denominator: Weighted Average Redeemable Class A ordinary shares
Redeemable Class A Ordinary shares, Basic and Diluted		8,496,531
Basic and Diluted net income per share, Redeemable Class A Ordinary shares	$	0.00

Non-Redeemable Ordinary shares
Numerator: Net Income minus Redeemable Net Earnings
Net Income	$	626,634
Redeemable Net Loss		(10,632	)
Non-Redeemable Net Income	$	616,002
Denominator: Weighted Average Non-Redeemable Ordinary shares
Basic and diluted weighted average shares outstanding, ordinary shares		3,307,469
Basic and diluted net loss per share, ordinary shares	$	0.19

Income Taxes

Recent Accounting Standards

XML 20 R9.htm IDEA: XBRL DOCUMENT

Initial Public Offering

3 Months Ended

Mar. 31, 2021

Initial Public Offering [Abstract]

Initial Public Offering

Note 4—Initial Public Offering

XML 21 R10.htm IDEA: XBRL DOCUMENT

Private Placement

3 Months Ended

Mar. 31, 2021

Private Placement Disclosure [Abstract]

Private Placement

Note 5—Private Placement

XML 22 R11.htm IDEA: XBRL DOCUMENT

Related Party Transactions

3 Months Ended

Mar. 31, 2021

Related Party Transactions

Note 6—Related Party Transactions

Founder Shares

Promissory Note—Related Party

Working Capital Loans

Administrative Support Agreement

XML 23 R12.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

3 Months Ended

Mar. 31, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 7—Commitments and Contingencies

Registration Rights

Underwriting Agreement

Business Combination Marketing Agreement

Open Market Purchases

XML 24 R13.htm IDEA: XBRL DOCUMENT

Warrants and Rights

3 Months Ended

Mar. 31, 2021

Warrants and Rights [Abstract]

Warrants and Rights

Note 8 -Warrants and Rights

●

at any time while the warrants are exercisable,

●

upon not less than 30 days’ prior written notice of redemption to each warrant holder,

●

XML 25 R14.htm IDEA: XBRL DOCUMENT

Shareholders' Equity

3 Months Ended

Mar. 31, 2021

Stockholders' Equity Note [Abstract]

Shareholders' Equity

Note 9—Shareholders’ Equity

XML 26 R15.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

3 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Fair Value Measurements

Note 10— Fair Value Measurements

Investment Held in Trust Account

	Amortized Cost and Carrying Value		Gross Unrealized Gains			Gross Unrealized Losses		Fair Value as of March 31, 2021
U.S. Money Market	$	7,995	$	-		$	-	$	7,995
U.S. Treasury Securities		91,545,039		(2,485	)		-		91,542,554
	$	91,553,034	$	(2,485	)	$	-	$	91,550,549

Warrant Liability

The following table presents the Company’s fair value hierarchy for liabilities measured at fair value on a recurring basis as of March 31, 2021:

	Level 1		Level 2		Level 3		Total
Warrant liabilities:
Private Warrants		-		-		173,783		173,783
Representative’s Warrant						246,340		246,340
Total warrant liabilities	$	-	$	-	$	420,123	$	420,123

There were no transfers between Levels 1, 2 or 3 during the three months ended March 31, 2021

	March 31, 2021			December 31, 2020
Exercise price	$	11.50		$	11.50
Share price	$	9.99		$	10.24
Volatility		12.5	%		11.7	%
Expected life		5.67			5.91
Risk-free rate		1.08	%		0.49	%
Dividend yield		-	%		-	%

The following table presents a summary of the changes in the fair value of the Private Warrants and Representative’s Warrants, a Level 3 liability, measured on a recurring basis.

	Warrant Liability
Fair value, December 31, 2020	$	1,156,512
Gain on change in fair value (1)		(736,389	)
Fair value, March 31, 2021	$	420,123

(1)

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 27 R16.htm IDEA: XBRL DOCUMENT

Subsequent Events

3 Months Ended

Mar. 31, 2021

Subsequent Events [Abstract]

Subsequent Events

Note 11—Subsequent Events

XML 28 R17.htm IDEA: XBRL DOCUMENT

Accounting Policies, by Policy (Policies)

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

Emerging Growth Company

Emerging Growth Company

Concentration of Credit Risk

Concentration of Credit Risk

Use of Estimates

Use of Estimates

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.

Investment Held in Trust Account

Investment Held in Trust Account

Fair Value Measurements

Fair Value Measurements

Derivative warrant liabilities

Derivative warrant liabilities

Offering Costs Associated with IPO

Offering Costs Associated with IPO

Class A Ordinary shares Subject to Possible Redemption

Class A Ordinary shares Subject to Possible Redemption

Net Loss Per Ordinary Share

Net Loss Per Ordinary Share

	For the Three Months ended March 31, 2021
Ordinary shares subject to possible redemption
Numerator: Net income allocable to Class A ordinary shares subject to possible redemption
Amortized Interest income on Treasury securities held in trust	$	10,632
Less: interest available to be withdrawn for payment of taxes		-
Net income allocable to Class A ordinary shares subject to possible redemption	$	10,632
Denominator: Weighted Average Redeemable Class A ordinary shares
Redeemable Class A Ordinary shares, Basic and Diluted		8,496,531
Basic and Diluted net income per share, Redeemable Class A Ordinary shares	$	0.00

Non-Redeemable Ordinary shares
Numerator: Net Income minus Redeemable Net Earnings
Net Income	$	626,634
Redeemable Net Loss		(10,632	)
Non-Redeemable Net Income	$	616,002
Denominator: Weighted Average Non-Redeemable Ordinary shares
Basic and diluted weighted average shares outstanding, ordinary shares		3,307,469
Basic and diluted net loss per share, ordinary shares	$	0.19

Income Taxes

Income Taxes

Recent Accounting Standards

Recent Accounting Standards

XML 29 R18.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Schedule of basic and diluted loss per ordinary share

	For the Three Months ended March 31, 2021
Ordinary shares subject to possible redemption
Numerator: Net income allocable to Class A ordinary shares subject to possible redemption
Amortized Interest income on Treasury securities held in trust	$	10,632
Less: interest available to be withdrawn for payment of taxes		-
Net income allocable to Class A ordinary shares subject to possible redemption	$	10,632
Denominator: Weighted Average Redeemable Class A ordinary shares
Redeemable Class A Ordinary shares, Basic and Diluted		8,496,531
Basic and Diluted net income per share, Redeemable Class A Ordinary shares	$	0.00

Non-Redeemable Ordinary shares
Numerator: Net Income minus Redeemable Net Earnings
Net Income	$	626,634
Redeemable Net Loss		(10,632	)
Non-Redeemable Net Income	$	616,002
Denominator: Weighted Average Non-Redeemable Ordinary shares
Basic and diluted weighted average shares outstanding, ordinary shares		3,307,469
Basic and diluted net loss per share, ordinary shares	$	0.19

XML 30 R19.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Schedule of carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities

	Amortized Cost and Carrying Value		Gross Unrealized Gains			Gross Unrealized Losses		Fair Value as of March 31, 2021
U.S. Money Market	$	7,995	$	-		$	-	$	7,995
U.S. Treasury Securities		91,545,039		(2,485	)		-		91,542,554
	$	91,553,034	$	(2,485	)	$	-	$	91,550,549

Schedule of fair value measured on recurring basis

	Level 1		Level 2		Level 3		Total
Warrant liabilities:
Private Warrants		-		-		173,783		173,783
Representative’s Warrant						246,340		246,340
Total warrant liabilities	$	-	$	-	$	420,123	$	420,123

Schedule of quantitative information regarding Level 3 fair value measurements

	March 31, 2021			December 31, 2020
Exercise price	$	11.50		$	11.50
Share price	$	9.99		$	10.24
Volatility		12.5	%		11.7	%
Expected life		5.67			5.91
Risk-free rate		1.08	%		0.49	%
Dividend yield		-	%		-	%

Schedule of fair value of warrant liabilities

	Warrant Liability
Fair value, December 31, 2020	$	1,156,512
Gain on change in fair value (1)		(736,389	)
Fair value, March 31, 2021	$	420,123

(1)

XML 31 R20.htm IDEA: XBRL DOCUMENT

Description of Organization, Business Operations and Basis of Presentation (Details) - USD ($)		3 Months Ended
	Nov. 12, 2020	Mar. 31, 2021
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]
Number of units (in Shares)	65,000
Number of purchase share (in Shares)	3,750,000
Market price per right (in Dollars per share)	$ 0.20
Cash underwriting fee		$ 1,575,000
Fair value of warrants		424,270
Other cash		653,250
Other offering cost		$ 593,861
Initial public offering, description	Following the closing of the IPO on November 12, 2020, $91,530,000 ($10.17 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (“Trust Account”) and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, until the earlier of: (i) the completion of a Business Combination, (ii) the redemption of any public shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation, and (iii) the redemption of the Company’s public shares if the Company is unable to complete the initial Business Combination within 24 months from the closing of the IPO (the “Combination Period”), subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholder.
Aggregate fair market value, percentage		80.00%
Outstanding voting securities percentage		50.00%
Business combination description		The Company will provide holders of the Company’s outstanding shares of Class A ordinary shares, par value $0.0001 per share, sold in the IPO (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares (as defined below) upon the completion of the initial business combination either (i) in connection with a shareholder meeting called to approve the initial business combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial business combination or conduct a tender offer will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially approximately $10.17 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations).
Net tangible assets least		$ 5,000,001
Redeem public shares, percentage		100.00%
Business combination agreement, description		The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.17 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.17 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of this offering against certain liabilities, including liabilities under the Securities Act.
Working capital		$ 727,773
Capital contribution		25,000
Cash		$ 727,773
Initial Public Offering [Member]
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]
Sale of stock (in Shares)	9,000,000	9,000,000
Sale of stock price per share (in Dollars per share)	$ 10.00	$ 10.00
Transaction cost		$ 3,246,381
Private Placement [Member]
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]
Private placement units (in Shares)	479,000
Proposed Public Offering [Member]
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]
Trust account per public share (in Dollars per share)		$ 10.00
I-Banker [Member]
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]
Number of purchase share (in Shares)	1,250,000
Market price per right (in Dollars per share)	$ 0.20

XML 32 R21.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Summary of Significant Accounting Policies (Details) [Line Items]
Foreign financial institutions man dated deposits	$ 250,000
Trust account held in marketable securities	$ 7,995
Common stock warrants issued (in Shares)	479,000
Deferred offering costs		$ 3,246,381
Underwriting fee		1,575,000
Representative’s warrants		424,270
Other cash	$ 653,250
Other offering costs		$ 593,861
Aggregate class A ordinary shares (in Shares)	6,137,400
Marketable securities [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Trust account held in marketable securities	$ 91,542,554
Initial Public Offering [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Common stock warrants issued (in Shares)	450,000
Class A Ordinary Shares [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Shares subject to possible redemption (in Shares)	8,558,147	8,558,147

XML 33 R22.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per ordinary share	3 Months Ended
	Mar. 31, 2021 USD ($) $ / shares shares
Numerator: Net income allocable to Class A ordinary shares subject to possible redemption
Amortized Interest income on Treasury securities held in trust	$ 10,632
Less: interest available to be withdrawn for payment of taxes
Net income allocable to Class A ordinary shares subject to possible redemption	$ 10,632
Denominator: Weighted Average Redeemable Class A ordinary shares
Redeemable Class A Ordinary shares, Basic and Diluted (in Shares) \| shares	8,496,531
Basic and Diluted net income per share, Redeemable Class A Ordinary shares	$ 0.00
Numerator: Net Income minus Redeemable Net Earnings
Net Income	626,634
Redeemable Net Loss	(10,632)
Non-Redeemable Net Income	$ 616,002
Denominator: Weighted Average Non-Redeemable Ordinary shares
Basic and diluted weighted average shares outstanding, ordinary shares (in Shares) \| shares	3,307,469
Basic and diluted net loss per share, ordinary shares (in Dollars per share) \| $ / shares	$ 0.19

XML 34 R23.htm IDEA: XBRL DOCUMENT

Initial Public Offering (Details) - $ / shares		3 Months Ended
Initial Public Offering (Details) - $ / shares	Nov. 12, 2020	Mar. 31, 2021
Initial Public Offering (Details) [Line Items]
Common stock, description		Each unit consists of one share of Class A ordinary shares, one-half warrant to purchase one share of Class A ordinary shares (“Public Warrants”), and one right (“Rights”). Each Public Warrant will entitle the holder to purchase one share of Class A ordinary shares at a price of $11.50 per share, subject to adjustment.
Expiration period		5 years
Initial Public Offering [Member]
Initial Public Offering (Details) [Line Items]
Sale of stock	9,000,000	9,000,000
Sale of stock price per share	$ 10.00	$ 10.00

XML 35 R24.htm IDEA: XBRL DOCUMENT

Private Placement (Details)	3 Months Ended
Private Placement (Details)	Mar. 31, 2021 USD ($) $ / shares shares
Private Placement (Details) [Line Items]
Aggregate additional shares purchase unit \| shares	65,000
Aggregate purchase price \| $	$ 479,000
Sale of Stock, Price Per Share \| $ / shares	$ 10.00
Redeem public shares, percentage	100.00%
Private Placement [Member]
Private Placement (Details) [Line Items]
Aggregate purchase price \| $	$ 4,790,000
Sponsor [Member]
Private Placement (Details) [Line Items]
Aggregate shares purchase \| shares	414,000

XML 36 R25.htm IDEA: XBRL DOCUMENT

Related Party Transactions (Details) - USD ($)			1 Months Ended	12 Months Ended
Related Party Transactions (Details) - USD ($)	Nov. 12, 2020	Nov. 09, 2020	Sep. 30, 2020	Dec. 31, 2020	Dec. 24, 2020
Related Party Transactions (Details) [Line Items]
Formation cost (in Dollars)	$ 177,591
Working capital loans (in Dollars)				$ 1,500,000
Additional price per unit (in Dollars per share)				$ 10.00
Office rent per month (in Dollars)		$ 10,000
Unsecured Promissory Note [Member]
Related Party Transactions (Details) [Line Items]
Principal amount (in Dollars)			$ 300,000
Over-Allotment Option [Member]
Related Party Transactions (Details) [Line Items]
Shares subject to forfeiture					337,500
Founder Shares [Member]
Related Party Transactions (Details) [Line Items]
Issuance of sponsor shares			2,875,000
Founder shares		287,500
Founder shares outstanding		2,587,500
Shares subject to forfeiture		337,500
Class B Ordinary Shares [Member]
Related Party Transactions (Details) [Line Items]
Issuance of sponsor shares			25,000
Issuance of price per share (in Dollars per share)			$ 0.01

XML 37 R26.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details) - USD ($)		3 Months Ended
Commitments and Contingencies (Details) - USD ($)	Nov. 12, 2020	Mar. 31, 2021
Commitments and Contingencies (Details) [Line Items]
Underwriters compensation		$ 653,250
Representative warrant description		The Company estimated the fair value of the Representative’s Warrant is $424,270 using the Monte Carlo simulation model. The fair value of the Representative’s Warrant to granted to the underwriters is estimated as of the date of grant using the following assumptions: (1) expected volatility of 24.1%, (2) risk-free interest rate of 0.60% and (3) expected life of 6.05 years. The expected volatility was determined by the Company based on the historical volatilities of a set of comparative special purpose acquisition companies (“SPAC”), and the risk-fee interest rate was determined by reference to the U.S. Treasury yield curve in effect for time period equals to the expected life of the Representative’s Warrant.
Cash underwriting discount		1.75%
Gross proceeds from issuance proposed public offering		$ 1,575,000
Percentage of advisory fee		2.75%
Payable to representative at closing balance		$ 2,475,000
Open market purchases, description		The Sponsor has agreed to enter into an agreement in accordance with the guidelines of Rule 10b5-1 under the Exchange Act, to place limit orders, through an independent broker-dealer registered under Section 15 of the Exchange Act which is not affiliated with the Company nor part of the underwriting or selling group, to purchase an aggregate of up to 3,750,000 of the Company’s rights in the open market at market prices, and not to exceed $0.20 per right during the period commencing on the later of (i) the date separate trading of the rights commences or (ii) sixty calendar days after the end of the “restricted period” under Regulation M, continuing until the date that is the earlier of (a) twelve (12) months from the date of the IPO and (b) the date that the Company announces that it has entered into a definitive agreement in connection with its initial Business Combination, or earlier in certain circumstances as described in the limit order agreement. The limit orders will require the Sponsor to purchase any rights offered for sale (and not purchased by another investor) at or below a price of $0.20, until the earlier of (x) the expiration of the buyback period or (y) the date such purchases reach 3,750,000 rights in total.
Purchase of additional market shares (in Shares)		1,250,000
Market share price to exceeds (in Dollars per share)		$ 0.20
Class A Ordinary Shares [Member]
Commitments and Contingencies (Details) [Line Items]
Issuance of underwriter shares (in Shares)	75,000
Price per share (in Dollars per share)	$ 0.01
Class A Ordinary Shares [Member] \| Warrant [Member]
Commitments and Contingencies (Details) [Line Items]
Purchase of warrant		$ 450,000

XML 38 R27.htm IDEA: XBRL DOCUMENT

Warrants and Rights (Details)	3 Months Ended
Warrants and Rights (Details)	Mar. 31, 2021
Warrants And Rights [Abstract]
Warrants, description	Each whole warrant entitles the holder to purchase one share of the Company’s Class A ordinary shares at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.50 per share of Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Company’s Sponsor or its affiliates, without taking into account any founder shares held by the Company’s Sponsor or its affiliates, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Value, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the Market Value.
Warrant expire term	5 years
Private warrants redemption, description	The Company may call the warrants for redemption (excluding the private warrants, and any outstanding Representative’s Warrants, and any warrants underlying units issued to the Sponsor, initial shareholders, officers, directors or their affiliates in payment of Working Capital Loans made to the Company), in whole and not in part, at a price of $0.01 per warrant: ●at any time while the warrants are exercisable, ● upon not less than 30 days’ prior written notice of redemption to each warrant holder, ● if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period ending on the third trading business day prior to the notice of redemption to warrant holders, and ● if, and only if, there is a current registration statement in effect with respect to the issuance of the Class A ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day until the date of redemption.

XML 39 R28.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details) - USD ($)			3 Months Ended
Shareholders' Equity (Details) - USD ($)	Dec. 24, 2020	Sep. 30, 2020	Mar. 31, 2021	Dec. 31, 2020	Nov. 09, 2020
Shareholders' Equity (Details) [Line Items]
Preferred stock, shares authorized			5,000,000	5,000,000
Preferred stock par value (in Dollars per share)			$ 0.0001	$ 0.0001
Forfeited shares	337,500
Business combination warrants, description			The Company’s initial shareholders have agreed not to transfer, assign or sell 50% its founder shares until the earlier to occur of (i) six months after the date of the consummation of the initial Business Combination or (ii) the date on which the closing price of the Company’s Class A ordinary shares equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after the initial Business Combination and the remaining 50% of the founder shares may not be transferred, assigned or sold until six months after the date of the consummation of the initial Business Combination, or earlier, in either case, if, subsequent to the initial Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the shareholders having the right to exchange their shares for cash, securities or other property.
Over-Allotment Option [Member]
Shareholders' Equity (Details) [Line Items]
Ordinary shares, shares issued			2,250,000
Class A ordinary shares [Member]
Shareholders' Equity (Details) [Line Items]
Ordinary shares, shares authorized			500,000,000
Ordinary shares, par value (in Dollars per share)			$ 0.0001
Ordinary shares, shares issued			995,853
Shares subject to possible redemption			8,558,147
Ordinary shares, shares outstanding			995,853
Class B ordinary shares [Member]
Shareholders' Equity (Details) [Line Items]
Ordinary shares, shares authorized			50,000,000	50,000,000
Ordinary shares, par value (in Dollars per share)			$ 0.0001	$ 0.0001
Ordinary shares, shares issued			2,250,000	2,250,000
Ordinary shares, subscribed		2,875,000
Ordinary shares, subscribed amount (in Dollars)		$ 25,000
Issued and outstanding share percentage (in Dollars)		$ 0.01
Ordinary shares, shares outstanding			2,250,000	2,250,000
Founder shares [Member]
Shareholders' Equity (Details) [Line Items]
Ordinary shares, shares issued					2,587,500
Initial stockholders holding an aggregate of founders shares					287,500

XML 40 R29.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details)	3 Months Ended
Fair Value Measurements (Details)	Mar. 31, 2021 USD ($) $ / shares
Fair Value Disclosures [Abstract]
Held in trust account cash	$ 7,995
Interest Income, Securities, US Treasury and Other US Government	$ 91,545,039
Strike price (in Dollars per share) \| $ / shares	$ 12

XML 41 R30.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details) - Schedule of carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities	3 Months Ended
	Mar. 31, 2021 USD ($)
Marketable Securities [Line Items]
Amortized Cost and Carrying Value	$ 91,553,034
Gross Unrealized Gains	(2,485)
Gross Unrealized Losses
Fair Value	91,550,549
U.S. Money Market [Member]
Marketable Securities [Line Items]
Amortized Cost and Carrying Value	7,995
Gross Unrealized Gains
Gross Unrealized Losses
Fair Value	7,995
U.S. Treasury Securities [Member]
Marketable Securities [Line Items]
Amortized Cost and Carrying Value	91,545,039
Gross Unrealized Gains	(2,485)
Gross Unrealized Losses
Fair Value	$ 91,542,554

XML 42 R31.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details) - Schedule of fair value measured on recurring basis	Mar. 31, 2021 USD ($)
Private Warrants [Member]
Fair Value Measurements (Details) - Schedule of fair value measured on recurring basis [Line Items]
Total warrant liabilities	$ 173,783
Representative’s Warrant [Member]
Fair Value Measurements (Details) - Schedule of fair value measured on recurring basis [Line Items]
Total warrant liabilities	246,340
Total warrant liabilities [Member]
Fair Value Measurements (Details) - Schedule of fair value measured on recurring basis [Line Items]
Total warrant liabilities	420,123
Level 1 [Member] \| Private Warrants [Member]
Fair Value Measurements (Details) - Schedule of fair value measured on recurring basis [Line Items]
Total warrant liabilities
Level 1 [Member] \| Total warrant liabilities [Member]
Fair Value Measurements (Details) - Schedule of fair value measured on recurring basis [Line Items]
Total warrant liabilities
Level 2 [Member] \| Private Warrants [Member]
Fair Value Measurements (Details) - Schedule of fair value measured on recurring basis [Line Items]
Total warrant liabilities
Level 2 [Member] \| Total warrant liabilities [Member]
Fair Value Measurements (Details) - Schedule of fair value measured on recurring basis [Line Items]
Total warrant liabilities
Level 3 [Member] \| Private Warrants [Member]
Fair Value Measurements (Details) - Schedule of fair value measured on recurring basis [Line Items]
Total warrant liabilities	173,783
Level 3 [Member] \| Representative’s Warrant [Member]
Fair Value Measurements (Details) - Schedule of fair value measured on recurring basis [Line Items]
Total warrant liabilities	246,340
Level 3 [Member] \| Total warrant liabilities [Member]
Fair Value Measurements (Details) - Schedule of fair value measured on recurring basis [Line Items]
Total warrant liabilities	$ 420,123

XML 43 R32.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements - $ / shares	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Schedule of quantitative information regarding Level 3 fair value measurements [Abstract]
Exercise price (in Dollars per share)	$ 11.50	$ 11.50
Share price (in Dollars per share)	$ 9.99	$ 10.24
Volatility	12.50%	11.70%
Expected life	5 years 244 days	5 years 332 days
Risk-free rate	1.08%	0.49%
Dividend yield

XML 44 R33.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details) - Schedule of fair value of warrant liabilities - Warrant Liability [Member]

3 Months Ended

Mar. 31, 2021

USD ($)

Fair Value Measurements (Details) - Schedule of fair value of warrant liabilities [Line Items]

Fair value, December 31, 2020

$ 1,156,512

Fair value, March 31, 2021

420,123

Gain on change in fair value

$ (736,389)

^[1]

[1]	Represents the non-cash gain on change in valuation of the Private Warrants and Representative’s Warrants and is included in Gain on change in fair value of warrant liability on the statement of operations.

EXCEL 45 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 46 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 47 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 48 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 62 264 1 true 24 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.adoc.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Balance Sheets Sheet http://www.adoc.com/role/ConsolidatedBalanceSheet Condensed Balance Sheets Statements 2 false false R3.htm 002 - Statement - Condensed Balance Sheets (Parentheticals) Sheet http://www.adoc.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Statement of Operations (Unaudited) Sheet http://www.adoc.com/role/ConsolidatedIncomeStatement Condensed Statement of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Statement Of Changes In Shareholders??? Equity (Unaudited) Sheet http://www.adoc.com/role/ShareholdersEquityType2or3 Condensed Statement Of Changes In Shareholders??? Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Statement Of Cash Flows (Unaudited) Sheet http://www.adoc.com/role/ConsolidatedCashFlow Condensed Statement Of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Description of Organization, Business Operations and Basis of Presentation Sheet http://www.adoc.com/role/DescriptionofOrganizationBusinessOperationsandBasisofPresentation Description of Organization, Business Operations and Basis of Presentation Notes 7 false false R8.htm 007 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.adoc.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Initial Public Offering Sheet http://www.adoc.com/role/InitialPublicOffering Initial Public Offering Notes 9 false false R10.htm 009 - Disclosure - Private Placement Sheet http://www.adoc.com/role/PrivatePlacement Private Placement Notes 10 false false R11.htm 010 - Disclosure - Related Party Transactions Sheet http://www.adoc.com/role/RelatedPartyTransactions Related Party Transactions Notes 11 false false R12.htm 011 - Disclosure - Commitments and Contingencies Sheet http://www.adoc.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 12 false false R13.htm 012 - Disclosure - Warrants and Rights Sheet http://www.adoc.com/role/WarrantsandRights Warrants and Rights Notes 13 false false R14.htm 013 - Disclosure - Shareholders' Equity Sheet http://www.adoc.com/role/ShareholdersEquity Shareholders' Equity Notes 14 false false R15.htm 014 - Disclosure - Fair Value Measurements Sheet http://www.adoc.com/role/FairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 015 - Disclosure - Subsequent Events Sheet http://www.adoc.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 016 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.adoc.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://www.adoc.com/role/SummaryofSignificantAccountingPolicies 17 false false R18.htm 017 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.adoc.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.adoc.com/role/SummaryofSignificantAccountingPolicies 18 false false R19.htm 018 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.adoc.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.adoc.com/role/FairValueMeasurements 19 false false R20.htm 019 - Disclosure - Description of Organization, Business Operations and Basis of Presentation (Details) Sheet http://www.adoc.com/role/DescriptionofOrganizationBusinessOperationsandBasisofPresentationDetails Description of Organization, Business Operations and Basis of Presentation (Details) Details http://www.adoc.com/role/DescriptionofOrganizationBusinessOperationsandBasisofPresentation 20 false false R21.htm 020 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.adoc.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.adoc.com/role/SummaryofSignificantAccountingPoliciesTables 21 false false R22.htm 021 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per ordinary share Sheet http://www.adoc.com/role/ScheduleofbasicanddilutedlossperordinaryshareTable Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per ordinary share Details http://www.adoc.com/role/SummaryofSignificantAccountingPoliciesTables 22 false false R23.htm 022 - Disclosure - Initial Public Offering (Details) Sheet http://www.adoc.com/role/InitialPublicOfferingDetails Initial Public Offering (Details) Details http://www.adoc.com/role/InitialPublicOffering 23 false false R24.htm 023 - Disclosure - Private Placement (Details) Sheet http://www.adoc.com/role/PrivatePlacementDetails Private Placement (Details) Details http://www.adoc.com/role/PrivatePlacement 24 false false R25.htm 024 - Disclosure - Related Party Transactions (Details) Sheet http://www.adoc.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.adoc.com/role/RelatedPartyTransactions 25 false false R26.htm 025 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.adoc.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.adoc.com/role/CommitmentsandContingencies 26 false false R27.htm 026 - Disclosure - Warrants and Rights (Details) Sheet http://www.adoc.com/role/WarrantsandRightsDetails Warrants and Rights (Details) Details http://www.adoc.com/role/WarrantsandRights 27 false false R28.htm 027 - Disclosure - Shareholders' Equity (Details) Sheet http://www.adoc.com/role/ShareholdersEquityDetails Shareholders' Equity (Details) Details http://www.adoc.com/role/ShareholdersEquity 28 false false R29.htm 028 - Disclosure - Fair Value Measurements (Details) Sheet http://www.adoc.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.adoc.com/role/FairValueMeasurementsTables 29 false false R30.htm 029 - Disclosure - Fair Value Measurements (Details) - Schedule of carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities Sheet http://www.adoc.com/role/ScheduleofcarryingvalueexcludinggrossunrealizedholdinglossandfairvalueofheldtomaturitysecuritiesTable Fair Value Measurements (Details) - Schedule of carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities Details http://www.adoc.com/role/FairValueMeasurementsTables 30 false false R31.htm 030 - Disclosure - Fair Value Measurements (Details) - Schedule of fair value measured on recurring basis Sheet http://www.adoc.com/role/ScheduleoffairvaluemeasuredonrecurringbasisTable Fair Value Measurements (Details) - Schedule of fair value measured on recurring basis Details http://www.adoc.com/role/FairValueMeasurementsTables 31 false false R32.htm 031 - Disclosure - Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements Sheet http://www.adoc.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements Details http://www.adoc.com/role/FairValueMeasurementsTables 32 false false R33.htm 032 - Disclosure - Fair Value Measurements (Details) - Schedule of fair value of warrant liabilities Sheet http://www.adoc.com/role/ScheduleoffairvalueofwarrantliabilitiesTable Fair Value Measurements (Details) - Schedule of fair value of warrant liabilities Details http://www.adoc.com/role/FairValueMeasurementsTables 33 false false All Reports Book All Reports adoc-20210331.xml adoc-20210331.xsd adoc-20210331_cal.xml adoc-20210331_def.xml adoc-20210331_lab.xml adoc-20210331_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2020-01-31 true true ZIP 50 0001213900-21-028876-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-21-028876-xbrl.zip M4$L#!!0 ( %J0N%)[/0Q3:'D .X2! 1 861O8RTR,#(Q,#,S,2YX M;6SLO?ESVTB6(/P[_PJLUSUAQU R#U&'J]H;\E6M[G))8\E=T[.Q40&120EM M$& #H&3U7[_OR!,708JZ;'S[39=,@LB7+U^^^_CY_WR;A=Z52-(@CO[\K+_= M>^:):!Q/@NCBS\^^G&X=GKX[.GKV?]YX7N?G_[6UY?TB(I'XF9AXYS?>NW@V M/QT'WEGB1^DT3F;>BVSVTMOR+K-L_OK5J^OKZ^TQ/)..@T2D\2(9BQ0_\+:V MX(7JE>\2@2]\[7V*(^^3?^,-=KQ!__7.$/Y_[\O9.V_0&_3Y)YV?OYTGH0
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end